The QualityStocks Daily Monday, January 13th, 2025

Today's Top 3 Investment Newsletters

QualityStocks(PHIO) $6.6000 +290.53%

MarketClub Analysis(SLRX) $3.6700 +134.50%

BioMedWire(KAPA) $2.1300 +119.59%

The QualityStocks Daily Stock List

Phio Pharmaceuticals (PHIO)

QualityStocks, StockMarketWatch, The Online Investor, Small Caps, Premium Stock Alerts, MarketBeat and 247 Market News reported earlier on Phio Pharmaceuticals (PHIO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Phio Pharmaceuticals Corp (NASDAQ: PHIO) (FRA: 44R3) is a biotechnology firm that is en-gaged in the development of immune-oncology therapeutics.

The firm has its headquarters in Marlborough, Massachusetts and was incorporated in 2011, on September 8th. Prior to its name change in November 2018, the firm was known as RXi Pharma-ceuticals Corp. It serves consumers in the United States.

The company’s mission is to develop innovative cancer treatments which overcome tumor immu-nosuppression and use the immune system to fight cancer without genetic modification. It uses its proprietary self-delivering RNAi platform to develop its therapeutics, as well as a topical im-munomodulatory known as Samcyprone which helps address patients’ unmet needs. The compa-ny is party to a collaboration with AgonOx Inc. which entails the clinical development of new T cell-based cancer immunotherapies. It is also party to collaborations with Helmholtz Zentrum München, Medigene AGand the Gustave Roussy.

The enterprise provides a therapeutic platform known as INTASYL, which is focused on silenc-ing tumor-induced suppression of an individual’s immune system. Its product pipeline comprises of a formulation dubbed PH-790, which targets the PD-L1 protein that prevents immune cells from attacking non-harmful cells in the body; and PH-804, which targets a suppressive immune receptor TIGIT, which acts as a checkpoint protein and is present on natural killer cells and T cells for use in adoptive cell transfer. It also develops PH-762, which targets PD-1 on immune cells used in adoptive cell transfer.

The company is focused on maximizing the value of its INTASYL technology, having presented positive data from in vivo preclinical studies which demonstrate the flexibility and application of the platform in the immuno-oncology field.

Phio Pharmaceuticals (PHIO), closed Monday's trading session at $6.6, up 290.5325%, on 281,979,243 volume. The average volume for the last 3 months is 22,610 and the stock's 52-week low/high is $1.53/$10.35.

Salarius Pharmaceuticals (SLRX)

QualityStocks, StockMarketWatch, Stocks That Move, MarketBeat, Broad Street, StocksEarning, Premium Stock Alerts, Money Wealth Matters and 360 Wall Street reported earlier on Salarius Pharmaceuticals (SLRX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Salarius Pharmaceuticals Inc. (NASDAQ: SLRX) (FRA: FP11) is a clinical stage biotechnology firm that is engaged in the development of cancer treatments that are epigenetic-based. Epigenetic refers to the regulatory system that influences gene expression.

Salarius Pharmaceuticals Inc. operates in the biotechnology industry, under the healthcare sector and is based in Houston, Texas. The firm, which was known as Flex Pharma Inc. before changing its name has been granted Product Development Award funding that totals $18.7 million by the Cancer Prevention and Research Institute of Texas in addition to other funding by the National Pe-diatric Cancer Foundation for the advancement of the Ewing sarcoma clinical program. Salarius Pharmaceuticals Inc. serves consumers and patients in the U.S. and was established in 2014.

Salarius Pharmaceuticals is party to strategic partnerships with the Cancer Prevention and Research Institute of Texas for various activities that entail product development; HLB Life Sciences for the development, manufacture, production and sale of the SP-2577 candidate in South Korea and the University of Utah Research Foundation for the license to patent rights that protect SP-2577 and associated compounds.

Salarius Pharmaceuticals Inc.’s product pipeline includes its lead candidate; seclidemstat, which is undergoing a phase 1/2 clinical trial for relapsed or refractory Ewing sarcoma. The candidate, which is also known as SP-2577, is also undergoing phase 1/2 clinical trials that evaluate its effica-cy in treating advanced solid tumors, including ovarian, breast and prostate cancers.

Salarius Pharmaceuticals (SLRX), closed Monday's trading session at $3.67, up 134.5048%, on 120,260,365 volume. The average volume for the last 3 months is 9,787,516 and the stock's 52-week low/high is $1.22/$7.20.

Avinger (AVGR)

MarketBeat, StockMarketWatch, StreetInsider, Marketbeat.com, The Stock Dork, Premium Stock Alerts, QualityStocks, BUYINS.NET, Barchart, The Online Investor, Zacks, TraderPower, TradersPro, Stock Beast, OTCtipReporter, Early Bird, Faisam Trader, MarketClub Analysis, Penny Pick Finders, Penny Stock Prodigy, PennyStockProphet, AwesomeStocks, Profitable Trader Authority, Promotion Stock Secrets, Street Insider, Timothy Sykes and PennyStockScholar reported earlier on Avinger (AVGR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Avinger Inc. (NASDAQ: AVGR) (FRA: VG2B) is a medical device firm that is focused on de-signing, manufacturing and commercializing catheter-based and image guided systems which are used by physicians to treat peripheral artery disease patients.

Avinger Inc. is based in Redwood City in California and was founded on March 8, 2007 by Himanshu N. Patel and John B. Simpson. Avinger Inc. is part of the medical equipment and sup-plies manufacturing industry and serves consumers in United States and also internationally. How-ever, the majority of the firm’s revenue is generated from sales in the U.S.

Avinger Inc. markets and sells its products to interventional radiologists and cardiologists as well as vascular surgeons. The firm is dedicated to changing the way vascular ailments are treated using its lumivascular platform.

Avinger Inc.’s products include the lumivascular platform, which has combined interventional catheters and optical coherence tomography visualization to offer intravascular imaging during pe-ripheral artery disease treatment. The firm’s lumivascular products are made up of an image-guided device used by physicians to remove arterial plaque in peripheral artery disease patients. These products include Pantheris, Ocelot catheters; Ocelot PIXL, Ocelot MVRX and Ocelot, which have been developed to penetrate blockages in arteries and Lightbox imaging consoles. Other products by the firm include Kittycat 2, Juicebox and Wildcat.

Avinger Inc. is the first company to manufacture an image-guided catheter-based system and was recently awarded an optical pressure sensor assembly patent. Majority of physicians prefer mini-mally invasive procedures, as they expose the patient to less risk and healing is faster. Avinger Inc. will continue to grow as it continues producing minimally invasive technologies, which will also be good for the company’s stocks.

Avinger (AVGR), closed Monday's trading session at $0.8031, up 42.6212%, on 9,782,190 volume. The average volume for the last 3 months is 6,556,795 and the stock's 52-week low/high is $0.39/$5.45.

GlucoTrack Inc. (GCTK)

QualityStocks, Premium Stock Alerts, PennyStockProphet, Money Wealth Matters, MarketClub Analysis, InvestorsUnderground, InsiderTrades and INO Market Report reported earlier on GlucoTrack Inc. (GCTK), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

GlucoTrack Inc. (NASDAQ: GCTK) is a medical device firm that is focused on designing, de-veloping and commercializing glucose monitoring devices for use by individuals suffering from diabetes and pre-diabetics.

The firm has its headquarters in Or Yehuda, Israel and was incorporated in September 2001, by David Malka and Avner Gal. Prior to its name change in November 2021, the firm was known as Integrity Applications Inc. The firm serves consumers around the globe, with a focus on the Asia Pacific, the United States, Israel and Europe.

The enterprise’s products include the GlucoTrack model DF-F, a glucose monitoring device which uses a patented combination of thermal, electromagnetic and ultrasound technologies to obtain glucose readings for pre-diabetic and diabetic patients in less than a minute, through the use of a small sensor that is clipped onto the individual’s earlobe using a Personal Ear Clip. The sensor contains calibration electronics and is linked to a handheld display and control unit. The monitoring device has been designed to obtain glucose measurements without drawing interstitial fluid or blood, making the device pain-free and needle-free. The enterprise also develops a wire-less module for the transmission of data of the glucose readings captured by the device to a cloud-based server.

GlucoTrack Inc. (GCTK), closed Monday's trading session at $0.1497, up 27.9487%, on 685,023,210 volume. The average volume for the last 3 months is 659,125 and the stock's 52-week low/high is $0.11/$4.95.

22nd Century Group (XXII)

QualityStocks, Schaeffer's, TraderPower, Broad Street, TradersPro, PennyStocks24, BUYINS.NET, Fierce Analyst, StockWireNews, StockMarketWatch, AwesomeStocks, InvestorPlace, Small Cap Firm, Pennybuster, MarketBeat, OTCBB Journal, StocksImpossible, Ceocast News, StockStreetWire, Marketbeat.com, The Street, First Penny Picks, StreetInsider, Money Morning, Promotion Stock Secrets, Jet-Life Penny Stocks, Wealth Insider Alert, StockEarnings, Daily Trade Alert, Investing Futures, MarketClub Analysis, InvestmentHouse, Nathan Gold, Investing Daily, Wise Alerts, Top Pros' Top Picks, Proactivecrg, CFN Media Group, StrategicTechInvestor, DreamTeamNetwork, Shah's Insights & Indictments, The Online Investor, Insider Financial, Matt Monaco, Street Insider, Mega Stock Alerts, Premium Stock Alerts, Leading Penny Stocks, Penny Stock, ProTrader, SmallCapNetwork and Stockgoodies reported earlier on 22nd Century Group (XXII), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

22nd Century Group Inc. (NASDAQ: XXII) is a biotechnology firm that is focused on the de-velopment of disruptive plant-based solutions for the pharmaceutical, consumer product and life science markets.

The firm has its headquarters in Buffalo, New York and was incorporated in 2005, on September 12th. It operates as part of the scientific research and development services industry. The firm serves consumers around the globe and has four companies in its corporate family.

The company focuses on technologies which alter the level of cannabinoids in cannabis or hemp plants and the level of nicotine in tobacco plants, through modern plant breeding techniques, as well as through gene-editing and genetic engineering. It is party to a collaboration with Keygene N.V. which entails the development of cannabis/hemp plants for extraordinary cannabinoid pro-files and other superior traits for agricultural, therapeutic and medical uses.

The enterprise is involved in the development of less harmful or modified risk tobacco products with low nicotine content, under the Moonlight Menthol and Moonlight names. These include a variable nicotine research cigarette dubbed Spectrum, which has been developed for use in inde-pendent clinical studies. It also develops a VLN 2.0 (very low nicotine) prototype cigarette through the use of its non-genetically modified technology.

The FDA recently authorized the marketing of the firm’s VNL Menthol King and VLN King re-duced nicotine cigarettes, making it the first product to receive modified risk tobacco product designation. This move will not only transform the tobacco industry but also have a positive ef-fect on the firm’s investments and growth.

22nd Century Group (XXII), closed Monday's trading session at $6, up 22.6994%, on 23,350,758 volume. The average volume for the last 3 months is 95,860 and the stock's 52-week low/high is $3.90/$581.85.

Goliath Resources Limited (GOTRF)

We reported earlier on Goliath Resources Limited (GOTRF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Goliath Resources has four separate option agreements to acquire 100 percent of these four highly pro-spective properties. These funds are now reserved for the newly drilled discovery of Au-Ag-Cu-Mo at the Lorne Creek Porphyry System on its Lucky Strike Property and High-Grade Polymetallic Gold Zone at the Sure Bet discovery on its Golddigger Property. All four properties have returned extensive minerali-zation of high grade Gold, Silver and/or Copper from exposed bedrock in situ at surface.

In October 2019, Goliath reported the original discovery of high-grade gold and polymetallic mineraliza-tion over a broad area on its 100 percent controlled Golddigger Property. The area is referred to as the Sure Bet Zone. It measures 1550m by 1130m and remains open in all directions.

In Quebec, the Company has its Nelligan East & West projects. Regarding the Nelligan East Project, gold mineralization is hosted in sulphide bearing quartz veins. It is mined to a vertical depth of -1,200m along a 2km strike length. Concerning the Nelligan West Project, it is positioned at the western end of the Nel-ligan trend, roughly 30km from the Nelligan Gold Deposit. Gold occurs in series of subparallel alteration zones, up to 200m wide.

Goliath Resources’ Bingo property encompasses 989 Hectares. It is only 10 kilometers from the historic Anyox historic mining camp, smelter, and power dam in the Golden Triangle. The Company’s Golddigger property covers 18,587 hectares. It is situated on tide water, 30 kilometers southeast of Stewart, British Columbia in the Golden Triangle.

Goliath’s Copperhead property encompasses 4,354 hectares. Copperhead is located 35 kilometers southwest of Smithers, British Columbia and positioned south of the Golden Triangle area. The Compa-ny’s Lucky Strike property encompasses 31,511 hectares. Lucky Strike is only 40 kilometers north of ma-jor infrastructure in Terrace, British Columbia.

Goliath Resources has substantially expanded on its previously documented mineralization at its Golddigger property in B.C.'s prolific Golden Triangle. A total of 179.85 meters of channel samples were taken in 2020 from multiple outcrops that contain massive and semi-massive sulphides inclusive of strongly silicified volcanic sediments from the SureBet Zone. The property is 7km West of the Dolly Var-den Mine access road providing for cost effective exploration.

Goliath Resources Limited (GOTRF), closed Monday's trading session at $0.8406, up 20.7065%, on 153,697 volume. The average volume for the last 3 months is 12,351,720 and the stock's 52-week low/high is $0.55/$1.01.

Realbotix (XBOTF)

We reported earlier on Realbotix (XBOTF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Realbotix Corp (OTCQB: XBOTF) (CVE: XBOT) (FRA: 76M0) is a company that creates cus-tomizable robots with human-like appearance and movements with the help of AI integration.

The firm has its headquarters in Toronto, Canada and was incorporated in 1998, on April 17th by Andrew Gabriel Kiguel. Prior to its name change in July 2024, the firm was known as To-kens.com Corp. It operates as part of the computer hardware industry, under the technology sec-tor. Realbotix serves consumers around the globe.

The company’s mission is to transcend the barrier between man and machine, with a reputation for having the highest quality humanoid robots and the most realistic silicone skin technology. Its proprietary AI is developed specifically for human companionship. It focuses on the integration of companionship-AI and robotics to improve the human condition through connection, learning and play. The company also owns an inventory of cryptocurrencies and a collection of crypto-related domain names. Its Robotic Head M3 includes a modular structure, 14 movable points, customizable face, customizable app, customizable AI, robust processor, and ultra-advanced eyes. The company’s manufacturing facilities are located in Nevada.

Realbotix recently unveiled its latest humanoid robot, Melody, at the 2025 Consumer Electronics Show. This open-source robot has been designed with upgraded features to improve functionali-ty, adaptability, and user experience. By incorporating advanced motor technology, the robot en-hances movement fluidity, modularity, and interaction, making her a versatile option for a variety of applications. This move may encourage additional investments into the company and help cre-ate additional value for its stakeholders.

Realbotix (XBOTF), closed Monday's trading session at $0.3344, off by 19.8082%, on 5,692,119 volume. The average volume for the last 3 months is 212,143,639 and the stock's 52-week low/high is $0.0601/$0.5097.

Precipitate Gold (PREIF)

We reported earlier on Precipitate Gold (PREIF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Precipitate Gold Corp. (OTCQB: PREIF) (CVE: PRG) is a mineral exploration firm focused on acquiring, exploring, exploiting, and developing mineral resources in the Dominican Re-public and Canada.

The firm has its headquarters in Vancouver, Canada and was incorporated in 2011, on January 31st. It operates as part of the gold industry, under the basic materials sector. The firm serves consumers around the globe.

Precipitate Gold explores for gold and base metal deposits. It is exploring and advancing its mineral property interests in Newfoundland, Canada and the Pueblo Viejo Mining Camp, and Tireo Gold Trend of the Dominican Republic. The enterprise's exploration projects include Pueblo Grande, Ponton, and Juan de Herrera. The Pueblo Grande project is subject to an Earn-In Agreement with Barrick Gold Corporation, with its land position surrounding the Pueblo Viejo mine site on the west, north and east sides, covering about 7,105.71 contiguous hectares. The Ponton project covers 3,250 hectares and is located 25km east of Pueblo Grande. It is an early-stage gold epithermal exploration target hosted in similar Los Ranchos Formation volcanic rocks as found at Barrick’s Pueblo Viejo. The 100% owned Juan de Her-rera project covers about 12,746 hectares and is located within the prospective Tireo Gold Trend of western Dominican Republic, directly adjoining GoldQuest Mining Corp on the south and west sides of its Tireo Gold project.

The company, which recently initiated a multi-staged fieldwork program at the Juan de Herre-ra Project that’ll focus on the project’s numerous established and newly developing gold and base metal zones and anomalies, remains focused on evaluating additional high-impact prop-erty acquisitions with the potential to expand its portfolio.

Precipitate Gold (PREIF), closed Monday's trading session at $0.0869, up 6.0403%, on 19,340 volume. The average volume for the last 3 months is 10,491,448 and the stock's 52-week low/high is $0.036/$0.1161.

PayPal Holdings Inc. (PYPL)

InvestorPlace, Kiplinger Today, The Street, MarketClub Analysis, Schaeffer's, MarketBeat, The Online Investor, Trades Of The Day, Daily Trade Alert, Zacks, StocksEarning, StockEarnings, StreetInsider, Early Bird, Investopedia, Market Intelligence Center Alert, The Wealth Report, Louis Navellier, Top Pros' Top Picks, GorillaTrades, Wealth Insider Alert, Barchart, StreetAuthority Daily, Marketbeat.com, QualityStocks, Daily Wealth, Trading Tips, Money Wealth Matters, StrategicTechInvestor, Cabot Wealth, MarketWatch, Trading Concepts, INO Market Report, Uncommon Wisdom, Daily Profit, Profit Confidential, FreeRealTime, CNBC Breaking News, TopStockAnalysts, Stansberry Research, Market Intelligence Center, Jon Markman’s Pivotal Point, Chaikin PowerFeed, Earnings360, Money and Markets, Money Morning, CustomerService, ProfitableTrading, Investors Alley, TipRanks, The Street Report, Wyatt Investment Research, TradeSmith Daily, TradersPro, SmallCapVoice, Smartmoneytrading, StockMarketWatch, Investment House, Investing Signal, Investing Daily, InsiderTrades, The Stock Dork, Eagle Financial Publications, Investiv, DividendStocks, AllPennyStocks, TheOptionSpecialist, Investing Lab, Stock Up Featured, Daily Dividends, Equities.com, Energy and Capital, Trader Prep, Traders For Cash Flow, Stock Market Watch, 24/7 Trader, SmallCapNetwork, Wall Street Daily, Wallstreet Journal, Weekly Wizards, WStreet Market Commentary, Penny Stock, BUYINS.NET, wyatt research newsletter, Average Joe Options, Schaeffer’s, Short Term Wealth, The 10-Minute Millionaire, The Motley Fool, Jim Cramer, Investors Underground, The Night Owl, Kiplinger’s Weekly Update, Investor Guide, The Best Newsletters, InvestmentHouse, Total Wealth, Rick Saddler, MarketClub, Milestone Capital Growth Portfolio, Investing Futures, Street Insider, MarketArmor.com, Insider Wealth Alert, INO.com Market Report, INO Traders Blog, The Disciplined Trader and Market FN reported earlier on PayPal Holdings Inc. (PYPL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

In 2024, PayPal (NASDAQ: PYPL) saw its shares rise by 39%, marking a significant achievement for the financial technology company. This growth allowed PayPal to outperform the S&P 500, which had a return of 23.3% during the same period. This is the first time in three years that PayPal has surpassed the S&P 500 in annual returns.

Despite this impressive annual performance, PayPal’s current stock price is $83.01, reflecting a slight decrease of $0.35, or approximately -0.42%. The stock has traded between $81.79 and $83.43 today, indicating some volatility. Over the past year, PayPal’s stock has reached a high of $93.66 and a low of $55.77, showing a wide range of price movements.

PayPal’s market capitalization is approximately $83.22 billion, highlighting its significant presence in the financial technology sector. The company’s trading volume for the day is 2,475,496 shares on the NASDAQ exchange, suggesting active investor interest. This level of trading activity can influence the stock’s price movements and overall market perception.

The company’s ability to outperform the S&P 500 in 2024 is noteworthy, especially considering the competitive landscape of the financial technology industry. PayPal’s performance may be attributed to strategic initiatives, product innovations, or market conditions that favored its business model. Investors will likely continue to monitor PayPal’s stock closely, given its recent achievements and market dynamics.

To view the company’s latest earnings release, visit https://ibn.fm/TGguP

About PayPal Holdings Inc.

PayPal has been revolutionizing commerce globally for more than 25 years. Creating innovative experiences that make moving money, selling and shopping simple, personalized and secure, PayPal empowers consumers and businesses in approximately 200 markets to join and thrive in the global economy. For more information, visit www.PayPal.com.

PayPal Holdings Inc. (PYPL), closed Monday's trading session at $83.99, up 0.7557582%, on 7,402,380 volume. The average volume for the last 3 months is 175,562 and the stock's 52-week low/high is $55.77/$93.66.

Compass Pathways PLC (CMPS)

InvestorBrandNetwork, QualityStocks, InvestorPlace, MarketBeat, PsychedelicNewsWire, Daily Trade Alert, Top Pros' Top Picks, StreetInsider, Schaeffer's, Prism MarketView, Trades Of The Day and The Street reported earlier on Compass Pathways PLC (CMPS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

A Minnesota Psychedelic Medicine Task Force is urging legislators to create a state-regulated program for legal therapeutic access to psychedelics and decriminalize the possession and use of low amounts of psilocybin. This government task force was established through a legislation signed by Governor Tim Walz into law in May 2024.

Originally, the task force was supposed to examine ketamine, mescaline, salvinorin A, ibogaine, DMT, bufotenine, 2C-B, and 5-MeO-DMT. Following the measure’s amendment, its focus shifted to LSD, psilocybin and MDMA.

Its responsibilities included advising legislators on the medical, policy, and legal issues linked to the legalization of psychedelic medicine in Minnesota. The task force is made up of 24 individuals including agency representatives and legislators as well as other individuals with experience in psychedelic medicine, substance use disorders, mental health, health policy, and veterans’ health who were appointed by the governor.

The panel was required to submit a final report with their recommendations and findings by January 1st.

In its report, the task force also encouraged legislators to allocate more state funds toward clinical research on psychedelics like LSD, psilocybin and MDMA. In addition to the official recommendations made by the panel, other ideas considered included decriminalization of personal use and possession of LSD and MDMA; commercial legalization of hallucinogenic mushrooms for adults; and a plan to decriminalize psilocybin that would also eliminate penalties around non-commercial sharing and cultivation.

The panel explained that while there were concerns that eliminating criminal and civil penalties would result in adverse events that’d negatively influence public safety and higher abuse rates, evidence from other jurisdictions that had implemented these policies had demonstrated that this was not the case.

They add that the removal of penalties would offer further protection for Minnesotans who wanted to take part in clinical psychedelic programs. Currently, only Colorado and Oregon have legalized psychedelic therapy programs in the U.S.

This report comes about a week before the state’s legislative session begins on January 14th.

Rep. Andy Smith, whose legislation established the task force, revealed in a recent interview that his intention and hope was to work to approve a bill that included the report’s formal recommendations. Other legislators who were part of the task force included Rep. Nolan West and Senators Mark Koran, Julia Coleman, Scott Dibble and Kelly Morrison.

Smith added that the task force would continue serving as a resource for legislators who were considering related measures before it disbands later this year.

The faltering pace at which psychedelic policy reform is happening at the state level suggests that the approach that is being taken by firms like Compass Pathways PLC (NASDAQ: CMPS) to develop FDA-approved medicines from these substances could be the most viable way forward if psychedelic treatments are to become widely available.

Compass Pathways PLC (CMPS), closed Monday's trading session at $3.37, off by 4.5326%, on 1,289,002 volume. The average volume for the last 3 months is 322,930 and the stock's 52-week low/high is $3.165/$12.75.

Canopy Growth Corp. (CGC)

InvestorPlace, Schaeffer's, The Street, StocksEarning, MarketClub Analysis, StockEarnings, Trades Of The Day, QualityStocks, MarketBeat, Daily Trade Alert, Kiplinger Today, The Online Investor, Wealth Insider Alert, Streetwise Reports, StreetInsider, CFN Media Group, Market Intelligence Center Alert, Investopedia, Zacks, Stock Up Featured, StreetAuthority Daily, Daily Profit, The Wealth Report, Early Bird, SmallCapVoice, Top Pros' Top Picks, StockMarketWatch, CannabisNewsWire, Wall Street Grand, Lebed.biz, SeriousTraders, INO Market Report, Profit Trends, Money Morning, BUYINS.NET, Louis Navellier, Cannabis Financial Network News, Jim Cramer, Inside Trading, Investors Underground, CNBC Breaking News, StocksToBuyNow, Outsider Club, Trading For Keeps, TradersPro, MarketClub, AllPennyStocks, Beat The Street, Wealth Daily, Cabot Wealth, VectorVest, Trading Concepts, Timothy Sykes, Tim Bohen, Profit Confidential, Technology Profits Daily, Insider Wealth Advice, Investment U, InvestmentHouse, Stock Gumshoe, Rick Saddler, Investors Alley, Raging Bull All Access, 24/7 Trader, Money and Markets and TheTradingReport reported earlier on Canopy Growth Corp. (CGC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The marijuana industry experienced a sluggish pace of progress in 2024. Efforts to pass cannabis reform measures in Congress fell short, and the DEA delayed rescheduling cannabis as a recognized medicinal substance.

Moreover, voter rejection of recreational cannabis legalization initiatives, including a high-profile defeat in Florida despite almost $150 million spent by multistate operators, suggests that easy reform opportunities may have reached their peak.

However, significant changes are looming. Relief from the burdens of Section 280E taxation appears closer, and with Donald Trump assuming office, he will become the first president to have publicly supported recreational cannabis legalization.

Here are the key developments anticipated in the industry for 2025:

  1. Rescheduling marijuana to Schedule 3

The DEA is expected to finalize the process of rescheduling cannabis as a Schedule III drug this year. Following a May 2024 proposal to alter marijuana’s federal classification, an administrative law judge will issue a decision after hearing extensive arguments. Regardless of the outcome, legal challenges are likely, and the Trump-appointed DEA administrator holds the authority to override the judge’s ruling.

  1. A pro-marijuana presidency?

For the first time since 2017, Republicans will control all three branches of government as Donald Trump begins his term. Many in the cannabis industry are optimistic, citing Trump’s past endorsement of Florida’s recreational cannabis legalization measure during his campaign.

However, his cabinet choices, including Attorney General nominee Pam Bondi—who has previously linked marijuana use to fentanyl addiction—suggest marijuana reform may not be a top priority. Although Trump could push for hearings on marijuana banking reforms, other pressing issues like the border crisis and opioid epidemic may delay significant action until after the 2026 midterms.

  1. Tax battles with the IRS

In a memo last year, the IRS reiterated that marijuana businesses must comply with Section 280E, preventing them from taking typical business deductions. Nevertheless, major operators claimed these deductions, sparking a potential legal showdown that could set critical precedents for the cannabis industry.

  1. California’s tax dilemma

California marijuana businesses owe the state $1.3 billion in taxes, with the excise tax set to rise to 19% this summer unless lawmakers intervene. High tax rates have long driven customers to the illicit market, straining legal operators. As the state faces a $20 billion budget deficit starting in 2026, lawmakers will likely face tough choices.

  1. Tighter controls on hemp-derived THC

Although Congress failed to update the Farm Bill to address the hemp THC loophole, several states, including California, enacted bans on intoxicating hemp products. Many experts believe uniform regulations for THC products are inevitable, though significant federal action may go past 2025.

  1. A Supreme Court showdown

Legal challenges to federal marijuana prohibition are intensifying. Attorneys for Verano Holdings and others argue that federal cannabis laws are unconstitutional, citing a 2005 Supreme Court decision. While lower courts have rejected these arguments, the case is expected to reach the Supreme Court by 2025, potentially setting a landmark precedent.

  1. State-level reforms stagnate

States like Pennsylvania have promised votes on recreational cannabis legalization, but progress remains slow. Recent defeats in South Dakota, North Dakota, and Florida leave state legislatures as the primary avenue for reform, though efforts in states like Minnesota and Delaware are still unfolding at a measured pace.

Cannabis firms like Canopy Growth Corp. (NASDAQ: CGC) (TSX: WEED) will be watching how the U.S. marijuana industry landscape shapes up as the year progresses and the new administration reveals more concrete plans for its stance on this substance.

Canopy Growth Corp. (CGC), closed Monday's trading session at $2.39, off by 2.449%, on 4,033,162 volume. The average volume for the last 3 months is 1,179,957 and the stock's 52-week low/high is $2.35/$14.92.

Fusion Fuel Green PLC (HTOO)

InvestorPlace, MarketBeat, Early Bird, QualityStocks, Premium Stock Alerts, MarketClub Analysis and InvestorsUnderground reported earlier on Fusion Fuel Green PLC (HTOO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Fusion Fuel Green (NASDAQ: HTOO), a provider of energy engineering and advisory solutions, announced the closing of a $1.28 million senior convertible notes private placement and an agreement for a $25 million equity line of credit with institutional investors. The notes, issued at a 20% original issue discount, mature in July 2026 with an 8% annual interest rate and include warrants offering 100% equity coverage. The equity line of credit allows Fusion Fuel to sell up to $25 million in Class A ordinary shares at its discretion, contingent on SEC registration, market conditions, and regulatory compliance. CEO John-Paul Backwell highlighted the capital’s role in strengthening liquidity, scaling the Al Shola Gas business, and advancing the BrightHy solutions platform to position the company as a leader in the energy services sector. Proceeds will bolster the balance sheet and fund strategic growth initiatives, with details available in the Form 6-K reports furnished to the SEC on Jan. 13, 2025.

To view the full press release, visit https://ibn.fm/1ln41

About Fusion Fuel Green PLC.

Fusion Fuel Green PLC (NASDAQ: HTOO) is an emerging leader in the energy services sector, offering a comprehensive suite of energy engineering and advisory solutions through its Al Shola Gas and BrightHy subsidiaries. Al Shola Gas provides full-service industrial gas solutions, including the design, supply, and maintenance of liquefied petroleum gas (LPG) systems, as well as the transport and distribution of LPG to a broad range of customers across commercial, industrial, and residential sectors. BrightHy, the Company’s newly launched hydrogen solutions platform, focuses on delivering innovative engineering and advisory services that enable decarbonization across hard-to-abate industries.

For more information, visit the company’s website at https://www.fusion-fuel.eu

Fusion Fuel Green PLC (HTOO), closed Monday's trading session at $0.54, off by 13.8756%, on 310,768 volume. The average volume for the last 3 months is 309,999 and the stock's 52-week low/high is $0.2825/$4.6499.

The QualityStocks Company Corner

D-Wave Quantum Inc. (NYSE: QBTS)

The QualityStocks Daily Newsletter would like to spotlight D-Wave Quantum Inc. (NYSE: QBTS).

D-Wave Quantum Inc. (NYSE: QBTS) ("D-Wave") announced that fiscal 2024 bookings will exceed $23 million, an approximately 120% increase from 2023, and fiscal Q4 bookings reached at least $18 million, an approximately 500% rise from $3 million in Q4 2023 bookings. The company also secured its first customer purchase of a D-Wave Advantage annealing quantum computing system, the world's largest quantum computer with over 5,000 qubits, marking a significant expansion in its revenue model by including on-premise system sales alongside its Leap™ quantum cloud service. D-Wave ended fiscal 2024 with a record approximately $178 million in cash.

To view the full press release, visit https://ibn.fm/1c6rA

D-Wave Quantum Inc. (NYSE: QBTS) is a leader in quantum computing systems, software and services focused on delivering customer value via practical quantum applications for problems such as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, fault detection and financial modeling. As the only provider building both annealing and gate-model quantum computers, the company is unlocking commercial use cases in optimization today, while building the technologies that will enable new solutions tomorrow.

D-Wave is a pioneer in quantum computing, with a history of delivering the world’s first commercial quantum computer; the first real-time quantum cloud service; countless hardware and software product and research milestones; and the planned first cross-platform quantum solution which will deliver both annealing and gate-model quantum computers to customers via an integrated platform. Its current commercial product offerings include: Advantage™ (fifth generation quantum computer), Leap™ (quantum cloud service), Launch™ (quantum computing onboarding service) and Ocean™ (full suite of open-source programming tools).

D-Wave’s relentless pursuit of practical quantum computing has resulted in the technology being used today by some of the world’s most advanced enterprises – more than 25 of the Forbes Global 2000 use D-Wave.

D-Wave’s commercial customers include blue-chip industry leaders like Volkswagen, Accenture, BBVA, NEC Corporation, Save-On-Foods, DENSO and Lockheed Martin. The company boasts an extensive IP portfolio featuring more than 200 issued U.S. patents and over 100 peer-reviewed papers published in leading scientific journals.

Founded in 1999, D-Wave is the world’s first commercial supplier of quantum computers. With headquarters and the Quantum Engineering Center of Excellence based near Vancouver, Canada, D-Wave’s U.S. operations are based in Palo Alto, California.

Advantage™ Quantum Computer

 

With the Advantage™ Quantum Computer, D-Wave has incorporated two decades of experience and over 10 years of customer feedback to create the first and only quantum computer designed for business. The platform features a new processor architecture with over 5,000 qubits and 15-way qubit connectivity. This is 2.5x more connections and more than double the number of qubits than the company’s previous generation quantum computer.

D-Wave’s quantum computers, first located in its facilities in British Columbia, have been available to North American users through its Leap™ quantum cloud service since 2018. It has since introduced new Advantage systems in Julich, Germany, and most recently, Marina Del Rey, California, which marked the availability of the first Advantage quantum computer physically located in the United States.

That new deployment is part of the USC-Lockheed Martin Quantum Computing Center (QCC) hosted at USC’s Information Sciences Institute (ISI), a unit of the University of Southern California’s prestigious Viterbi School of Engineering. Additionally, Amazon Web Services (AWS) and D-Wave announced that the U.S.-based system is available for use in Amazon 2racket, expanding the number to three different D-Wave quantum systems available to AWS users.

Leap Quantum Cloud Service

 

D-Wave’s customers interface with its systems through the Leap™ quantum cloud service. Leap delivers immediate, real-time access to the company’s Advantage quantum computer and quantum hybrid solver service, all with enterprise-class performance and scalability.

Leap allows developers proficient in Python to get started building and running quantum applications. Through a seamless and secure cloud-based connection, users can easily start solving complex problems of up to 1 million variables and 100,000 constraints.

Using Leap, D-Wave customers have developed quantum hybrid applications for use cases in manufacturing, logistics, financial services, life sciences, materials science, retail and transportation. By eliminating the need to wait hours, days or weeks to get good answers to a broad array of problems, D-Wave is helping businesses move forward.

D-Wave Launch

D-Wave Launch™ is the company’s onboarding platform aimed at helping businesses easily start their quantum journey. Through this program, D-Wave’s team of experts and partners aid enterprises in identifying best use cases for quantum and work with them to develop a proof of concept and production pilot.

From there, the team coordinates with customers to get their hybrid quantum applications up and running, providing ongoing Leap quantum cloud access to ensure the application is operating smoothly and delivering real business value.

Target Verticals

While the potential applications for quantum computing are effectively limitless, D-Wave has identified a number of industry verticals as key areas of focus for its quantum architecture, providing case studies for each. These include:

  • Manufacturing – D-Wave worked with Volkswagen to identify a commercial optimization application, the binary paint shop problem, which was run on D-Wave’s hybrid solver service. The solver outperformed four purely classical methods on problem sizes at commercial scale (N=3,000). In a separate project, similar inputs were tested using a leading ion trap system, which failed to find any commercial solution.
  • Life Sciences – Menten AI makes use of D-Wave quantum computing to assist in the design of novel therapeutic peptides—short strings of amino acids that can act as potent drugs. With the rise of COVID-19, D-Wave’s Advantage system made it possible to identify molecules that might be especially well-suited for binding and inhibiting the related spike protein, producing several promising peptide designs.
  • Finance – Multiverse Computing, a leader in developing quantum solutions for the financial sector, leveraged D-Wave’s hybrid solver service in a collaboration with BBVA, one of the world’s largest financial institutions. Multiverse demonstrated management strategies that far exceeded the granularity of traditional returns in a fraction of the time, helping BBVA identify a low-risk portfolio for investment.

Market Opportunity

The quantum computing total addressable market is projected to grow between $450 billion and $850 billion over the next 15 to 30 years, with between $5 billion and $10 billion of anticipated TAM growth coming in the next three to five years, according to Boston Consulting Group. Driving factors behind this growth include rising investments in quantum computing tech by governments and an increasing number of commercial use-cases.

Forward-thinking organizations see quantum as an opportunity to move ahead of the competition. From finding efficiencies and reducing waste to decreasing time to solution and solving problems abandoned due to complexity, the business value is real. According to data from 451 Research, 40% of large enterprises are already experimenting with quantum computing.

D-Wave is strategically positioned – in an industry with significant barriers to entry – as evident by a decades-long track record serving a roster of blue-chip customers. The company is singularly focused on helping its customers achieve clear value by leveraging quantum computing in practical business applications. With a full stack of systems, software, developer tools and services, D-Wave is working to enable enterprises, governments, developers and researchers to access the power of quantum computing, thereby providing an intriguing opportunity for prospective investors.

D-Wave’s current investor base includes PSP Investments, Goldman Sachs, BDC Capital, NEC Corporation, Aegis Group Partners and In-Q-Tel.

Leadership Team

Dr. Alan Baratz has served as the CEO of D-Wave since 2020. Previously, as Executive Vice President of R&D and Chief Product Officer, he drove the development, delivery, and support of all of D-Wave’s products, technologies, and applications. Dr. Baratz has over 25 years of experience in product development and bringing new products to market at leading technology companies and software startups. As the first president of JavaSoft at Sun Microsystems, he oversaw the growth and adoption of the Java platform from its infancy to a robust platform supporting mission-critical applications in nearly 80 percent of Fortune 1000 companies. He has also held executive positions at Symphony, Avaya, Cisco, and IBM. Dr. Baratz holds a doctorate in computer science from the Massachusetts Institute of Technology.

John Markovich is the company’s CFO. He brings to D-Wave over three decades of experience working with rapidly growing private and public technology companies across all stages of development. Mr. Markovich has directed the finance, accounting, tax, treasury, M&A, legal, operations, customer service, IR, HR, and IT functions for companies ranging from privately held pre-revenue startups to an NYSE-listed Fortune 500 multi-national company with over $1.2 billion in annual revenue. During his career, he has negotiated and closed over 150 debt, equity, M&A, and joint venture transactions exceeding $2.5 billion in value; over a dozen private placements; nearly a dozen M&A transactions; and several international joint ventures. Mr. Markovich holds a BS in Business from Miami University and an MBA from the Michigan State Graduate School of Business.

D-Wave Quantum Inc. (NYSE: QBTS), closed Monday's trading session at $3.83, off by 33.6222%, on 5,172,295 volume. The average volume for the last 3 months is 98,920,088 and the stock's 52-week low/high is $0.6813/$11.41.

Recent News

FingerMotion Inc. (NASDAQ: FNGR)

The QualityStocks Daily Newsletter would like to spotlight FingerMotion Inc. (NASDAQ: FNGR) .

Demand for big data software is expected to surge in the coming years as more firms leverage big data analytics to improve service delivery and increase efficiency. Recent forecasts show that the global Big Data Processing and Distribution Software market will enjoy a compound annual growth rate (CAGR) of 12.08% between 2024 and 2031. The market's 2024 valuation of around $10.53 billion is set to double over the projected period and reach $20.87 billion when the decade draws to a close. While companies have used data analytics to optimize their operations and boost revenue for well over a decade, the switch to online commerce coupled with the recent deployment of artificial intelligence (AI), machine learning, and generative AI has allowed firms to analyze vast data sets. The market will remain integral to the industry as a decision-making tool as the amount and variety of data that companies collect expands. Machine learning and artificial intelligence will play a notable role in the market's expansion as they will allow companies to gain insights from gargantuan data sets. Cloud computing will also play a role in the growth of the Big Data Processing and Distribution Software market. More companies are expected to shift large portions of their operations to cloud computing as they seek to lower the expenses associated with physical hardware, making it easier for them to incorporate big data software into their operations. Enterprises like FingerMotion Inc. (NASDAQ: FNGR) that provide Big Data analytics services are poised to benefit from the growing demand for services geared at helping firms to leverage the huge amounts of data available today.

FingerMotion Inc. (NASDAQ: FNGR) is an evolving technological company with core competencies in mobile payment and recharge platform solutions in China. FingerMotion is in the process of developing additional value-added technologies to market to users.

Founded in 2016, FingerMotion’s goal is to serve over a billion users in the Chinese market and expand its model to other regional markets. The company has offices in Hong Kong, Shanghai and New York City.

Current Offerings

FingerMotion is analyzing and transforming mobile data to improve the lifestyle of the public through technology and innovation. The company’s current offerings include:

  • Telecommunications Products and Services – FingerMotion’s proprietary universal exchange platform, ‘PigeonHole Integration System (PIS)’, offers seamless integration between telecom operators and online stores. The service platform’s offerings include top up and recharge, data plan, mobile phone, loyalty points redemption and subscription plans. The platform offers reliable and secure transactions, real-time reconciliation, simple integration for partners and efficient settlements.
  • SMS and MMS Services – The integrated platform is registered as FingerMotion’s IP in China and provides a robust back-end control panel for corporate partners to manage their own messaging settings. FingerMotion’s clients range from insurance to financial industries, ecommerce firms, airlines and more. The platform offers competitive pricing for partners and provides quick and efficient review to meet timely marketing initiatives.
  • Big Data Insights – FingerMotion brings Big Data-enabled insurance solutions through its Big Data Insights arm, Sapientus. The company’s strategic partnerships with the largest Chinese telecommunications giants allow access to uncover behavior insights through geolocation and mobile data usage. Its Big Data offerings include risk scoring, precise marketing, simplified underwriting and customized products.
  • Rich Communication Services (RCS) – FingerMotion’s RCS platform will be a proprietary business messaging solution that enables businesses and brands to communicate their services to customers via 5G infrastructure. The company expects its RCS platform to offer a better user experience, more efficiency and cost-effectiveness when compared to other solutions.

Telecommunications and Insurtech Markets

The global telecommunications market was valued at $1.74 trillion in 2019 and is expected to grow at a CAGR of 5% from 2020 to 2027. The steady increase is expected to be driven by the adoption of 5G and the increased popularity of Internet of Things (IoT) applications.

The Chinese telecom market was valued at $254.1 billion in 2017 and is also constantly expanding. The current Chinese telecom market is dominated by three mobile operators – China Mobile, China Unicom and China Telecom, which together are responsible for around 1.6 billion active subscribers (https://ibn.fm/zfwy9).

In addition, the insurtech (insurance technology) market was valued at $2.72 billion globally in 2020 and is expected to grow at a CAGR of 48.8% from 2021 to 2028. The large increase is attributed to the rising use of technology solutions for everyday activities like acquiring insurance coverage (https://ibn.fm/TGo7D).

Through its proprietary platforms and technologies, FingerMotion is uniquely positioned to capitalize on the telecom and insurtech markets’ growth and opportunities.

Management Team

Martin J. Shen is the Chief Executive Officer of FingerMotion Inc. He has over 15 years of experience in senior management roles within entrepreneurial startups and large multinational corporations. He has acquired a wide range of corporate management, financial oversight and operation administration expertise through these roles. In his most recent role, he founded Imperial Distributors (formerly known as AP Martin Pharmaceutical Supplies Ltd.), establishing the company as the preferred choice for distributional support to regional pharmacies throughout Western Canada. Before founding Imperial, Mr. Shen served as the Chief Operating Officer and Chief Financial Officer at Wales and Son Industrial (formerly Weir Minerals), a firm specializing in global delivery and support for mining slurry equipment. He began his career at PricewaterhouseCoopers in Vancouver, with work tours in the tax department in Singapore and the tax audit and advisory group in Hong Kong. Mr. Shen is a U.S. Certified Public Accountant and holds a Bachelor of Science from the University of British Columbia.

Lee Yew Hon is the company’s Chief Financial Officer. From 2006 until November 2020, he was the Chief Financial Officer of Cubinet Interactive Group of Companies, and he also took on the Chief Operating Officer role in 2011. During his tenure, he was instrumental in leading Cubinet and building teams across the Southeast Asia region, setting up financial processes within a short time. Mr. Lee spearheaded the growth of Cubinet to other regions, including Europe, the Middle East and Russia. He received his diploma from Tunku Abdul Rahman College in 1996. He is a Chartered Accountant, a member of the Malaysia Institute of Accountants (MIA) and an Associate Member of the Chartered Institute of Management Accountants, UK (ACMA).

Li Li is the Senior Vice President of FingerMotion. She recently served as Advisor to Shenzhen WuYiKa Technology Co. Ltd., a comprehensive service platform dedicated to online service distribution and payment. The company has become a fast and efficient provider of new media marketing solutions for the mobile internet. She has held high-level management positions with multiple industry names, including Hangzhou JiuYue Information Technology Co. Ltd. and Hangzhou LingXuan Information Technology. Ms. Li started her career in 2004, founding Shanghai ChuangYeZZ Network Technology Co. Ltd. and serving as its Vice President. With the close cooperation of local operators, the company launched SMS, MMS, WAP, mobile JAVA games, Hunan Satellite TV e-magazine and other wireless internet services to meet the rapid development of wireless internet and application requirements. She received her degree from Nanjing Academy of Engineering.

FingerMotion Inc. (FNGR), closed Monday's trading session at $1.17, up 1.7391%, on 4,059 volume. The average volume for the last 3 months is 500,906 and the stock's 52-week low/high is $11.41/$.

Recent News

Calidi Biotherapeutics Inc. (NYSE American: CLDI)

The QualityStocks Daily Newsletter would like to spotlight Calidi Biotherapeutics Inc. (NYSE American: CLDI).

Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotechnology company focused on targeted immunotherapies, has priced its public offering of 5,000,000 shares of common stock at $0.85 per share, with gross proceeds expected to total approximately $4.25 million before fees and expenses. The offering, exclusively placed by Ladenburg Thalmann & Co. Inc., is set to close on or around Jan. 10, 2025, subject to customary conditions. Proceeds will support working capital and general corporate purposes. The shares are offered under an effective Form S-3 registration statement, with a final prospectus available on the SEC's website or through Ladenburg Thalmann.

To view the full press release, visit: https://ibn.fm/Rqtwg

Calidi Biotherapeutics Inc. (NYSE American: CLDI) is a clinical-stage immuno-oncology company pioneering proprietary technology that empowers the immune system to combat cancer. Calidi’s innovative, off-the-shelf cell-based platforms use allogeneic stem cells to deliver potent oncolytic viruses (OVs) across multiple oncology indications, including high-grade glioma (brain cancers) and solid tumors. In addition, Calidi has presented a breakthrough systemic technology, RTNova, which utilizes an exteracellular enveloped virotherapy. RTNova is pre-clinical and has been extremely well-received by market analysts and large-cap biopharma – opening the door for potential collaboration.

These cell-based platforms are engineered to protect, amplify, and enhance the efficacy of oncolytic viruses, resulting in improved patient safety and potentially advancing treatment outcomes for metastatic disease. By employing a dual approach that combines OV delivery with immune activation, Calidi’s therapies aim to not only treat but potentially prevent the spread of metastatic cancers.

The company’s development pipeline leverages this technology to address pressing needs in cancers such as glioblastoma (brain cancer), metastatic melanoma, triple-negative breast cancer, head & neck cancer, and lung cancer. Calidi’s approach has shown early signals of efficacy and safety, establishing it as a distinctive player in the growing OV market, which is projected to increase significantly in value over the next decade.

Calidi is headquartered in San Diego, California.

Products

Calidi’s product pipeline includes advanced cell-based platforms targeting a variety of oncology indications, each designed to harness the power of oncolytic virotherapy for improved cancer treatment outcomes.

  • NeuroNova (CLD-101): A platform designed for treating high-grade gliomas (HGG), NeuroNova employs neuronal stem cells combined with an engineered adenovirus (CRAD-s-Pk7) to selectively target glioma cells. After a successful Phase 1 safety study in newly diagnosed HGG, NeuroNova has now progressed into Phase 1/1b trials for recurrent cases. FDA clearance for a Phase 1b/2 trial at Northwestern University was received in September 2024, with patient enrollment expected to begin in Q1 2025. This trial will utilize multiple-dose intracerebral administration to maximize safety and efficacy in newly diagnosed HGG patients.
  • SuperNova (CLD-201): Built on Calidi’s foundational technology, SuperNova utilizes an engineered Vaccinia virus (CAL1) delivered via allogeneic adipose-derived mesenchymal stem cells to target advanced solid tumors, including head & neck, triple-negative breast cancer, and soft tissue sarcomas. Early studies with autologous stem cells demonstrated both safety and promising efficacy, and Calidi plans to begin a Phase 1 trial with multiple dose regimens for SuperNova in the coming months.
  • RTNova (CLD-400): Calidi’s systemic delivery platform for lung and metastatic cancers, RTNova employs an extracellular enveloped virotherapy (envRT-01) technology for intravenous (IV) administration, simplifying the treatment process and expanding its potential applications. Currently in preclinical stages, RTNova focuses on demonstrating efficacy and safety through systemic administration. A clinical trial targeting metastatic lung cancer is anticipated for Q2 2026, using a single-arm monotherapy with dose escalation. Calidi has partnered with SIGA Technologies (NASDAQ: SIGA) to support the development of this program.

Market Opportunity

The global oncology drugs market was valued at $201.75 billion in 2023 and is projected to grow to $518.25 billion by 2032, with a CAGR of 11.3%. The oncolytic virotherapy market in particular is growing rapidly, driven by increasing approval rates and significant unmet needs.

The market for OV treatments is expected to expand from one approved product generating $150 million in the U.S. in 2021 to 6-8 approved therapies generating $2.4 billion by 2030. As a leader in OV technology, Calidi is well-positioned to address these high-demand areas in oncology.

Alongside global trends, the American Cancer Society projects nearly two million new cancer diagnoses in the U.S. in 2024, reflecting a 28% increase since 2010. This underscores the urgent need for novel therapies that not only treat disease progression but also enhance patient quality of life, reinforcing the demand for Calidi’s innovative approaches.

Management Team

Allan Camaisa, CEO, Chairman, and co-founder, is a seasoned leader with extensive experience in scaling businesses to successful exits. Mr. Camaisa previously led High Technology Solutions, growing it from two employees to over 500 with $50 million in revenue. He also served as CEO of Parallel6 Inc. and is a U.S. Naval Academy graduate with further studies at Harvard Business School.

Antonio Santidrian, Ph.D., Chief Scientific Officer, leads all research and development initiatives at Calidi and is the coinventor of the company’s CLD-201 (Supernova) and CLD-400 (RTNova) platforms. Since joining Calidi in 2015, he has applied his 20+ years of expertise in academia and biotech, focusing on anti-cancer translational research, to drive the company’s innovative drug pipeline. Before Calidi, Dr. Santidrian led translational studies at The Scripps Research Institute, advancing treatments for breast cancer metastasis, and contributed to the development of ACADRA for chronic lymphocytic leukemia (CLL) at the University of Barcelona, Spain.

Boris Minev, M.D., President of Medical and Scientific Affairs, is a renowned physician-scientist with expertise in Immuno-Oncology, stem cell biology, and oncolytic viruses. Previously, Dr. Minev served as Director of Immunotherapy and Translational Oncology at Genelux Corporation and remains an adjunct professor at the Moores UCSD Cancer Center. His background includes research at the National Cancer Institute.

Andrew Jackson, CFO, has held executive finance roles with experience in biotech and clinical-stage companies, including Eterna Therapeutics and Ra Medical Systems. Mr. Jackson holds an MSBA in Finance from San Diego State University and a BSB in Accounting from the University of Minnesota.

Calidi Biotherapeutics Inc. (NYSE American: CLDI), closed Monday's trading session at $0.9188, up 0.4153005%, on 24,842 volume. The average volume for the last 3 months is 1,158,243 and the stock's 52-week low/high is $0.73/$16.80.

Recent News

Horizon Fintex | Upstream

The QualityStocks Daily Newsletter would like to spotlight Horizon Fintex | Upstream

The gaming industry has always been about embracing new technology to improve player experiences. From the first Nintendo console to the internet-driven World of Warcraft and smartphone hits like Candy Crush Saga, each leap in technology has brought something new to gaming. Now the next big step is Web3 gaming, and Telegram is emerging as a key player in this space. Web3 gaming represents a new era of gaming built on blockchain technology. This means games are not just for fun; they also offer players real ownership of in-game items like tokens or characters. These assets can be traded, sold, or used in other games. On top of that, players can earn rewards just by playing. The potential for Web3 gaming is enormous. With the integration of technology like TON and the support of platforms like Telegram, gaming could become more rewarding, fun, and inclusive. Telegram is proving that gaming, payments, and messaging can work together seamlessly. By making blockchain gaming simple and enjoyable, Telegram is helping to shape the next big evolution in the gaming industry. With these innovations, the future of Web3 gaming looks brighter than ever. As more people use Web3 gaming to familiarize themselves with this new technology, it is likely that they will develop a greater appreciation of the services of entities like Horizon Fintex that are powered by Web3.

Horizon Fintex is a software business specializing in compliant securities solutions. The company aims to facilitate the future of capital markets by leveraging the regulatory experience of Wall Street bankers and the proven track record of technology veterans to bring focus to compliance, efficiency, security and transparency.

Horizon’s flagship product is the revolutionary trading app ‘Upstream’, a MERJ Exchange Market, and the first regulated market powered by a blockchain to offer both digital securities and NFT trading. Upstream traders experience T+0 settlement, best bids and offers displayed on a transparent public orderbook that prevents predatory market practices – all from a user-friendly trading app.

Products

Horizon Fintex offers a full suite of end-to-end blockchain-enhanced software solutions to create a seamless experience for both issuers and investors. Its product suite includes:

  • Securitization & IssuanceETSware is an end-to-end Electronic Trading System streamlining capital raising from primary issuance through compliant secondary trading.
  • KYC Compliance OnboardingKYCware is a white label Know Your Customer (KYC) and Anti-Money Laundering (AML) compliance software solution offering best-in-class cryptographic security to compliantly onboard and verify user identity through a smartphone application.
  • AML Screening SoftwareAMLCop offers advanced Anti-Money Laundering (AML) software to streamline the verification of user details against a proprietary database of global sanctions, politically exposed persons (PEPs) and watchlists.
  • Cap. Table Management ToolsCustodyWare equips registered U.S. transfer agents with next-generation cap. table management software to manage securities on behalf of their clients pursuant to an SEC-registered or exempt securities offering.
  • Exchange & Trading App TechnologyOpen Order Book offers Ethereum blockchain securities exchange software to power the next generation of trading venues for digital assets.

Upstream – The Horizon-Powered Trading App

Upstream is a joint venture with MERJ Exchange (merj.exchange), an affiliate of the World Federation of Exchanges.

Upstream aims to be the premiere global trading hub offering issuers around the world exposure to a digital-first investor base that can trade using USDC digital currency along with credit, debit, PayPal, and USD (fiat) to increase liquidity and enhance price discovery; while also offering investors access to dual-listed companies, IPOs, crowdfunded companies, U.S. & Int’l. equities, digital coupons and NFTs directly from a user-friendly trading app.

Upstream aims to unlock liquidity for investors of all levels while offering industry-leading levels of transparency, accessibility and investor protections enforced using Ethereum blockchain technology.

Management Team

Brian Collins is the CEO of Horizon Fintex. He founded the company in 2010. From 1999-2010, Mr. Collins was CEO of Abbey Technology in Switzerland, specializing in the design of trading software for Swiss banks. Prior to this, he worked for Credit Suisse in Zürich, designing and building proprietary equity trading solutions. Mr. Collins graduated in 1990 with a BS in Computer Systems from the University of Limerick, Ireland.

Mark Elenowitz is the company’s President. He is a Wall Street veteran with over 29 years of experience. Mr. Elenowitz was the co-founder of a U.S. broker dealer and is Managing Director of two U.S. broker dealers, responsible for advising clients on compliance, capital structure and capital market navigation. He was responsible for leading the first successful Reg A+ IPO of a company to list on the NYSE and others which listed directly onto Nasdaq. He is a noted speaker at Small Cap and Reg A events, including the SEC Small Business Forum, and has been profiled in BusinessWeek and CNBC, as well as several other publications. Mr. Elenowitz is a graduate of the University of Maryland School of Business and Management with a BS in Finance and holds Series 24, 62, 63, 79, 82 and 99 licenses.

Dr. Andrew Le Gear is the CTO of Horizon Fintex. Prior to joining the company in 2013, he worked as a software engineer with Dell Inc. (2012-2013) and Lehman Brothers and Nomura Plc. (2007-2012). Dr. Le Gear was a co-founder of Juneberi Ltd., a research-driven software tech start-up (2004-2007). He graduated in 2006 with a Ph.D. in Computer Science from the University of Limerick, Ireland.

Peter Hall is the company’s CIO. Prior to joining Horizon Fintex in 2011, he worked at Microsoft (2008-2011), Atos Origin (2004-2008) and AIT Group Plc. (1998-2002). Mr. Hall has held CISSP certification since 2010. He graduated from the University of Sheffield, UK in 1995 and earned an MS from the University College London in 2006.

Mike Boswell is the CFO of Horizon Fintex. A Wall Street veteran, he co-founded a U.S. broker dealer and served as Chief Compliance Officer. Mr. Boswell was also Managing Director of TriPoint Capital Advisors, a merchant banking and financial consulting company, and CFO of Mission Solutions Group, a privately held defense sector firm. He earned an MBA from John Hopkins University and a BS in Mechanical Engineering from the University of Maryland. Mr. Boswell holds Series 24, 62, 63, 79, 82 and 99 licenses.

Recent News

chart

Adageis

The QualityStocks Daily Newsletter would like to spotlight Adageis

Adageis, a forward-thinking healthcare technology company reshaping patient care through flexible AI-centric software solutions, is in support of the Centers for Medicare and Medicaid Services' ("CMS") switching from the V24 to the V28 upgrade of the Hierarchical Condition Categories ("HCC") model. "The transition from CMS-HCC V24 to V28 reflects a critical update to the risk adjustment model used in Medicare Advantage… The more precise structure enhances diagnostic specificity, allowing for better patient categorization. This change supports value-based care by tying payments more closely to actual patient needs," reads a recent article.

"The CMS-HCC transition aligns closely with Adageis's mission of revolutionizing patient care through innovative value-based care solutions. The company's ProActive Care Platform leverages AI-driven predictive analytics to optimize care and reimbursement, making it uniquely suited to help healthcare providers navigate these changes… By integrating seamlessly with existing electronic medical records (‘EMRs') and reducing the barriers to adoption, Adageis empowers organizations to meet the challenges of the V28 model. The platform's ability to identify high-risk patients and streamline care planning is crucial as providers adjust to new risk-scoring dynamics."

To view the full article, visit https://ibn.fm/6Og60

Adageis is a healthcare technology company dedicated to revolutionizing patient care through innovative solutions. By integrating artificial intelligence (AI) and machine learning, Adageis addresses inefficiencies in healthcare delivery, enabling providers to enhance patient outcomes and streamline operations. The company focuses on leveraging advanced technology to meet the growing demand for value-based care and quality incentives in the healthcare sector.

With a commitment to innovation and practical solutions, Adageis empowers clinics, healthcare centers, and care networks to implement its ProActive Care Platform without the need for expensive platform changes or extensive staff training. This approach reduces barriers to adoption and helps healthcare organizations maximize their potential in an increasingly complex industry landscape.

Recent collaborations, including its partnership with HealthyU Clinics and integration with AthenaHealth as a marketplace partner, underscore Adageis’s industry relevance and adaptability.

Adageis is headquartered in Mesa, Arizona.

Services

Adageis offers the ProActive Care Platform, an AI-driven solution designed to integrate seamlessly with existing Electronic Medical Records (EMR) systems.

This platform enables healthcare providers to deliver patient-centric care while maximizing reimbursements from quality metrics and value-based contracts. Key features include:

  • Predictive Analytics: Utilizes AI to analyze patient data, identifying high-risk individuals and care gaps to improve health outcomes and reduce costs.
  • Efficiency and Cost Reduction: Continuously monitors patient health, allowing providers to offer proactive care even outside traditional office visits, thereby enhancing efficiency and lowering expenses.
  • Flexible Integration: Compatible with various EMR systems, including AthenaHealth, Cerner, eClinicalWorks, Allscripts, and Epic, facilitating easy adoption without the need for extensive staff training or platform changes.

Market Opportunity

The global AI in healthcare market is experiencing rapid growth, driven by the increasing demand for enhanced efficiency, accuracy, and better patient outcomes. In 2023, the market was valued at approximately $19.27 billion by Grand View Research, and it is projected to grow at a compound annual growth rate of 38.5% from 2024 to 2030. This growth is fueled by the increasing need for solutions that can analyze large datasets, reduce costs, and improve care delivery across the healthcare continuum.

Adageis is well-positioned to capitalize on these trends. Its ProActive Care Platform offers AI-driven predictive analytics and proactive care solutions that align with the industry’s shift toward value-based care. By providing seamless integration with existing EMR systems and focusing on operational efficiency, Adageis enables healthcare providers to meet the demands of a rapidly evolving market.

Leadership Team

Shane Speirs, MD, MBA serves as the company’s CEO. He is a board-certified physician in family and geriatric medicine with extensive experience in healthcare leadership, data modeling, and AI applications in healthcare delivery. He holds an MBA in Healthcare Management from the W.P. Carey School of Business and has a proven track record in managing telehealth and AI-focused healthcare companies.

Bill Jentarra, MBA is the CTO of Adageis, bringing over 25 years of experience in architecting and implementing complex client relationship management (CRM) and business intelligence (BI) solutions across various industries, including healthcare. His expertise encompasses the entire lifecycle of CRM and BI projects, ensuring practical and cost-effective technology applications to solve complex business problems.

Recent News

chart

SuperCom Ltd. (NASDAQ: SPCB)

The QualityStocks Daily Newsletter would like to spotlight SuperCom Ltd. (NASDAQ: SPCB) .

SuperCom (NASDAQ: SPCB), a global provider of secure solutions for the e-Government, Internet of Things ("IoT"), and cybersecurity sectors, announced it has secured an electronic monitoring ("EM") contract with a Juvenile Probation Agency in Ohio. This marks SuperCom's first project in the state and its sixth new U.S. market entry since summer 2024, as well as its 20th new EM contract during the same period, highlighting its expansion in delivering innovative public safety solutions. The project will utilize SuperCom's PureOne technology, which offers real-time GPS tracking, secure communication, and compliance tools in a discreet, humane design to support rehabilitation and reduce stigma. By displacing the incumbent provider, SuperCom enabled the agency to adopt its PureSecurity platform, delivering enhanced operational control and cost efficiency while tailoring solutions to correctional and juvenile programs that promote reintegration and public safety.

To view the full press release, visit https://ibn.fm/cIu38

SuperCom Ltd. (NASDAQ: SPCB) provides secured solutions for the e-government, IoT and cybersecurity sectors. Since 1988, the company has been a trusted global provider of traditional and digital identity offerings, providing cutting-edge electronic and digital security solutions to governments and organizations, both private and public, around the world.

SuperCom’s mission is to revolutionize the public safety sector worldwide through proprietary electronic monitoring technology, data intelligence, and complementary services.

The company is headquartered in Tel Aviv, Israel, with offices in California and other regions in the U.S.

Business Units

IoT and Connectivity

SuperCom IoT products and solutions provide advanced electronic monitoring solutions and services to criminal justice agencies, enabling customers to detect unauthorized movement of people, vehicles, and other monitored objects. The company provides an all-in-one, field-proven PureSecurity offender monitoring suite, accompanied by services such as GPS monitoring, home detention, domestic violence prevention, and more. The company’s services are specifically tailored to meet each client’s needs.

SuperCom’s proprietary Puresecurity suite of hardware, connectivity, and software components is the foundation for its criminal justice services and offerings. SuperCom is leveraging its extensive technology expertise to implement groundbreaking artificial intelligence (AI) technologies into various parts of its core offerings. By leveraging the power of AI, SuperCom’s PureSecurity platform can offer new abilities, such as amplified data analysis, predictive modeling, and streamlined automation – all geared toward optimizing decision-making and operational efficiency.

Competitive advantages of SuperCom’s technology include:

  • Long Battery Life (No Tag Charging Required)
  • Ultra Lightweight Form Factor
  • Next-Gen Location Tech
  • Protection of Domestic Violence Victims
  • And More

 

Cybersecurity

In 2015, SuperCom identified the cybersecurity market as a fast-growing space with significant advantages due to synergistic technologies and a shared customer base with its e-Gov and IoT business units. Consequently, SuperCom strategically acquired Prevision Ltd., a company with a strong presence in the market and a broad range of competitive cybersecurity services.

During the first quarter of 2016, SuperCom acquired Safend Ltd., an international provider of cutting-edge endpoint data protection guarding against corporate data loss and theft through content discovery and inspection, encryption methodologies, and comprehensive device and port control.

Both acquisitions significantly expanded the breadth of the company’s global cybersecurity capabilities.

e-Gov

Through proprietary e-government platforms and innovative solutions for traditional and biometrics enrollment, personalization, issuance, and border control services, SuperCom has helped governments, and national agencies design and issue secured multi-identification, or Multi-ID, documents and robust digital identity solutions to their citizens, visitors, and lands.

The company has focused on expanding its activities in the traditional identification, or ID, and electronic identification, or e-Gov, markets, including the design, development, and marketing of identification technologies and solutions to governments in Europe, Asia, America, and Africa using SuperCom’s e-Government platforms.

Market Opportunity

Data from Berg Insight estimates the market for electronic monitoring solutions will grow from $1.2 billion in 2021 to $2.1 billion in 2026, marking a CAGR of 10.8% for the forecast period.

High recidivism rates, prison overcrowding, and soaring incarceration costs are some factors that are driving the electronic monitoring of offenders’ market growth.

An analysis by ReportLinker forecasts that the global cybersecurity market will grow from an estimated value of $173.5 billion in 2022 to $266.2 billion by 2027, achieving a CAGR of 8.9% for the period.

The increased number of data breaches worldwide, the ability of malicious actors to operate from anywhere in the world, the links between cyberspace and physical systems, and the difficulty of reducing vulnerabilities and consequences in complex cyber networks are some factors driving the cybersecurity market growth.

Management Team

Ordan Trabelsi is President and CEO of SuperCom. He has over 15 years of experience as CEO, growing high-tech companies globally. He also has experience in research and development and product innovation, as well as hands-on experience in cybersecurity, encryption, advanced mathematics, and mobile and internet network technologies. Prior to joining SuperCom, he served as co-founder and CEO of Klikot Inc., a global social networking company. He holds an MBA from Columbia University and a B.Sc. in Computer Engineering from The Technion: Israel Institute of Technology.

Barak Trabelsi is COO of SuperCom. He has expertise in big data, cyber, mobile, and internet network technologies, as well as extensive experience in product development and strategies. Prior to joining SuperCom, he served as Senior Product Manager at Equinox Ltd. Before that, he served for four years as VP of R&D at Sigma Wave, a wireless, security, and internet-focused company. He holds a B.Sc. in Computer Science and Business, as well as an MBA from Tel Aviv University.

Gil Alfi is VP of Sales at Safend Ltd., SuperCom’s cybersecurity subsidiary. He joined SuperCom in 2016 as VP of Business Development for Safend. He has more than 18 years of experience in technology companies. He served as an R&D team technology lead for more than seven years and as Director of Product Management for various telecom and wireless companies for more than 10 years. Prior to joining SuperCom, he served as Regional Sales Director at Safend, managing sales regions in Europe and Africa. He holds a B.Sc. in Computer Science and Mathematics and an M.Sc. in Computer Science from Bar-Ilan University.

SuperCom Ltd. (NASDAQ: SPCB), closed Monday's trading session at $8.09, off by 16.9405%, on 4,340 volume. The average volume for the last 3 months is 2,330,363 and the stock's 52-week low/high is $2.55/$10.90.

Recent News

McEwen Mining Inc. (NYSE: MUX) (TSX: MUX)

The QualityStocks Daily Newsletter would like to spotlight McEwen Mining Inc. (NYSE: MUX) (TSX: MUX).

McEwen Mining (NYSE: MUX) (TSX: MUX) was highlighted in a recent article that discussed favorable positioning of the United States in the AI sector. "Sam Altman, the CEO of OpenAI, has voiced his confidence in President-elect Donald Trump supporting the AI sector and ensuring that America, together with its allies, retain pole position in this nascent industry. Altman was speaking during a recent interview with Fox News," the publication reads. "During the interview, Altman highlighted the need for support in the form of massive infrastructure… for the U.S. to stamp its leadership on AI technology and AI capabilities."

"Tech giants like Microsoft, Meta Platforms, Alphabet Inc., Amazon and so many others are frantically building out data centers and other attendant systems in order to stamp their mark on the AI field. This race to set up AI infrastructure and applications has created market opportunities for companies like McEwen Mining (NYSE: MUX) (TSX: MUX) that extract the minerals critical to the AI industry."

To view the full article, visit https://ibn.fm/CuSwc

McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) is an asset rich diversified gold and silver producer in the Americas with a large exposure to copper through its subsidiary, McEwen Copper, owner of the Los Azules copper deposit in Argentina, believed to be the 8th largest undeveloped copper resource in the world.

Led by a management team with a track record of success, MUX owns and operates mines in some of the most prolific gold producing regions of the Americas. The company proactively took cost-saving measures months ago to lower expenses and increase production across its portfolio of gold assets, driving some production costs below industry averages. Gold and copper prices, already in an upswing, are forecast to enter an explosive uptrend over the next couple years. Drawing from its experience, McEwen Mining planned, prepared and laid the groundwork to capitalize on this emerging opportunity.

The company currently holds a Zacks Rank #1 (Strong Buy), placing it in the top 5% of over 4,000 stocks ranked by Zacks, based on trends in earnings estimate revisions and EPS surprises. Seldom is management so aligned with investors’ interests and committed to the company’s success. With a combined investment of over $220 million, CEO Rob McEwen holds a 17% ownership stake in McEwen Mining and a 13% ownership in McEwen Copper. Acclaimed in the mining industry, McEwen founded Goldcorp, where he increased the company’s market capitalization 160 times – from $50 million to over $8 billion. That same vision and tenacity led MUX in creating McEwen Copper.

For McEwen Mining shareholders, beyond the company’s exposure to gold upsurges, its 47.7% stake in McEwen Copper is expected to be a blockbuster, turbocharging MUX by creating the world’s next prolific copper unicorn.

McEwen Copper

With continuous industrial need, new critical demand for copper is rapidly emerging, increasingly driven by the green energy transition. The price of copper rose from a low of about $2 per pound in 2020 to over $4.60 per pound in May 2024, and strong demand is expected to intensify. A study by S&P Global, titled The Future of Copper: Will the Looming Supply Gap Short-circuit the Energy Transition?, projects global copper demand to nearly double over the next decade, from 25 million metric tons today to about 50 million metric tons by 2035. Based on current trends, S&P Global forecasts annual supply shortfalls to reach nearly 10 million metric tons in 2035.

McEwen Mining owns a 47.7% equity stake in McEwen Copper, the holder of a 100% interest in the Los Azules copper project in San Juan, Argentina, which is ranked the 8th largest undeveloped copper deposit in the world. Current copper resources at Los Azules are estimated at 10.9 billion pounds at a grade of 0.40% Cu (Indicated category) and an additional 26.7 billion pounds at a grade of 0.31% Cu (Inferred category). McEwen Copper also owns a copper exploration project in Nevada, USA, called Elder Creek.

In a 2023 Preliminary Economic Assessment (PEA), Los Azules was estimated to have a 27-year life, producing an average of 322 million lbs. of copper cathode annually, at a cash cost of $1.07 per lb. of copper, in the lowest quartile of the copper cost curve. The project could ultimately become an even larger mine with a longer life, since the extent of mineralization has not been fully assessed on the property.

The project’s 2023 PEA presents a distinctly different development strategy from a prior PEA published in 2017. By proposing a heap leach project using solvent extraction-electrowinning instead of the previously detailed mine with a conventional mill and flotation concentrator, McEwen Copper aims to decrease its environmental footprint and reduce permitting risk, albeit with a lower overall copper recovery, slightly higher unit costs and a delay in immediate cashflow due to extended leach cycles.

After securing a $25 million investment from mining giant Rio Tinto’s technology arm, Nuton LLC, McEwen Copper closed its non-brokered, private placement offering of $82 million in August 2022. Shortly after, in February 2023, Nuton agreed to invest an additional $30 million into McEwen Copper, and in October 2023, Nuton once again expanded its stake, investing an additional $10 million to bring its ownership position in McEwen Copper to 14.5%.

“We are extremely pleased to have Nuton’s strong continued participation in McEwen Copper,” Rob McEwen stated in a news release. “Together we are exploring new technologies that save energy, water, time and capital in the pursuit of delivering green copper to Argentina and the world, a product that will contribute to the electrification of transportation and the protection of our atmosphere.”

Also in February 2023, FCA Argentina S.A., a subsidiary of Stellantis N.V., one of the world’s leading automakers, invested ARS $30 billion in McEwen Copper. In October 2023, Stellantis invested an additional ARS $42 billion, bringing its current stake in McEwen Copper to 19.4%.

“We are delighted to have Stellantis as a partner in the future development of our Los Azules copper project,” Rob McEwen said of the investment. “Together, we share a vision to build a mine for the future based on regenerative principles that can achieve net-zero carbon emissions by 2038.”

Following the capital raise, McEwen Copper is well-funded to advance its Los Azules Project, with a Feasibility Study planned for Q1 2025. MUX strategically reduced its interest to increase its treasury, in order to reduce debt and fund the further development of its gold and silver assets.

Gold & Silver Projects

The Fox Complex

McEwen Mining owns a 100% stake in the Fox Complex in the heart of a prolific gold district in Timmins, Canada.

“When MUX bought the Fox Complex, in late 2017, it was a distressed asset with a history of high operating cost/oz. While it has taken longer than I expected, the cost to produce an ounce of gold is significantly lower,” CEO Rob McEwen stated in a news release.

McEwen Mining issued 2024 guidance for its cash cost/oz at the Fox Complex of $1,225-1,325 on annual production of 40,000-42,000 GEOs. Fox Complex produced 44,450 GEOs in 2023, which was within the company’s guidance range.

Located in one of the most prolific gold production areas in the world, along the Destor-Porcupine Fault Zone within the Abitibi Greenstone Belt, the Fox Complex includes the Black Fox mine and Froome mine which together have yielded over 1,000,000 ounces of gold to date. Also, the complex includes the Grey Fox and Stock deposits that have over 1,800,000 ounces in gold resources. The 2.7-billion-year-old Abitibi Greenstone Belt, formed by ancient volcanic activity, has proved to be one of the world’s richest and most abundant gold regions, with a total gold content currently estimated at over 300 million ounces.

In 2024, MUX commenced development of underground ramp access to the Stock orebodies at the Fox Complex. This development will become the primary source of feed following the completion of mining the Froome deposit in 2026. As part of the future mining sequence initiative, the company has already reported a 31% year-over-year increase of gold resources at Stock West and Stock Main (historical Stock Mine), with confirmation of good grading structures plunging to depth. It has also identified Stock East as a potential new near-term source of future revenue.

The Gold Bar Mine

McEwen Mining owns a 100% stake in the Gold Bar mine, located in an area well known for gold production, the southern Roberts Mountains of the Battle Mountain-Eureka-Cortez gold trend in Eureka County, Central Nevada. The Gold Bar mine is on the same geological structure, 25 miles south of Nevada Gold Mines, a Barrick-Newmont joint venture, part of the Cortez-Goldrush complex. This complex contains estimated reserves and resources of over 50 million gold ounces, with an annual production of 1,000,000 gold ounces.

Gold Bar had been mined between 1991 and 1994, producing 134,000 gold ounces. A new facility was built by MUX in 2019. Gold Bar accounted for 42,700 GEOs in 2023, within the company’s guidance for the year. For 2024, McEwen Mining issued guidance of 40,000-43,000 at a cash cost of $1,450-1,550. The first half of the year is expected to deliver higher production relative to the second half, due to a scheduled waste stripping phase in the Pick pit, in preparation for the 2025 mining program.

Notably, in April 2024, McEwen Mining announced its entry into a definitive agreement and plan of merger with Timberline Resources Corporation (TSX.V: TBR) (OTCQB: TLRS) in a transaction valued at roughly $18.8 million. The merger with Timberline is expected to augment McEwen’s existing portfolio of development and exploration projects in Nevada, leveraging synergies between Timberline’s projects and the Company’s Gold Bar mine.

El Gallo/Fenix

Project Fenix is the proposed redevelopment plan for McEwen Mining’s El Gallo Complex in Mexico. There is a long history of mining in this region. MUX began operating it as an open pit, heap leach mine in 2013, which produced 281,000 gold equivalent ounces at average cash cost of $655 per ounce. Due to the transition to deeper sulfide mineralization that is not amenable to heap leaching, mining activities ceased in the second quarter of 2018 and residual heap leaching followed until mid-2022. The redevelopment plan envisions constructing a mill at the existing mine site that will initially reprocess the existing heap leach material, then transition to open pit mining and processing of the sulphide mineralization. The company recently acquired a complete process plant on very advantageous terms that has considerably reduced the projected capital requirements for the project.

CEO Rob McEwen stated in a news release, “This acquisition has made Fenix more attractive to build and could provide a new long life mine for McEwen Mining.”

The initial development approach is to build a mill to reprocess the material on the heap leach pad and produce approximately 17,000 oz of gold annually for eight years. Construction of the Fenix project is expected to begin in the second half of 2024.

San José Mine

McEwen Mining is a 49% owner and non-operator of the San José gold and silver mine, located in Santa Cruz province, Argentina, encircling Newmont’s prolific Cerro Negro (approx. 300,000 gold ounces produced in 2023). This high-grade underground mine has been operating since 2007 and currently has an expected life of six years with a reserve grade of 296 gpt silver and 5.4 gpt gold.

Exploration is continuing to extend high-grade veins and discover new veins at the complex. San José’s drilling programs to define additional resources and reserves have a long history of success due to a high vein density, aided by good geophysical response from hidden veins.

Production guidance for 2024 for MUX’s 49% interest is 50,000-60,000 GEOs. As a minority shareholder in the mine, MUX equity accounts for its investment in San José, and receives 49% of the dividends from the mine’s free cash flow.

Market Outlook

Mining stocks suffered significant losses in the wake of the COVID-19 pandemic. However, this has turned, and many analysts now forecast a gold bull market in 2024 and beyond.

“The operating challenges we faced in recent years have severely damaged our credibility with our shareholders and the market. As a result, few investors have taken a close look recently at our assets,” Rob McEwen said in a news release. “If they did, I believe some would see the potential value that I see today… I believe there is considerable potential value in MUX, and that is a big reason why I have a personal financial commitment of $220 million in MUX and McEwen Copper.”

Management Team

Robert R. McEwen is Chairman, CEO and Chief Owner of McEwen Mining. He has been associated with the gold industry all his career, with his first 18 years in the investment industry and, since 1990, as CEO of several gold mining companies. He founded Goldcorp and took that company from a $50 million market capitalization to more than $8 billion. He owns 17% of McEwen Mining and is in complete alignment with investors – his investment in MUX and McEwen Copper is $220 million and he takes an annual salary of only $1. He was awarded the Order of Canada and the Queen Elizabeth’s Diamond Jubilee Award, was inducted into the Mining Hall of Fame, was named an Ernst and Young Entrepreneur of the Year and has Honorary Doctor of Law degrees from York University and Western University.

William Shaver is interim COO and a Director of McEwen Mining. He has decades of management and executive experience in mine design, construction and operations. He was a founder of Dynatec Corporation, which became one of the leading contracting and mine operating groups in North America. In 2013, he was recognized as Ernst and Young Entrepreneur of the Year. Most recently, he served as COO of INV Metals. He is a Professional Engineer with a B.Sc. in Mining Engineering from Queens University.

Perry Ing is interim CFO at McEwen Mining. He has 25 years of experience in the Canadian mining industry. Over the past 15 years, he has held positions as CFO of Mountain Province Diamonds, Kirkland Lake Gold and McEwen Mining. Prior to that, he worked at Barrick Gold and Goldcorp and started his career in the mining practice at PwC. He has a Bachelor of Commerce from the University of Toronto and is a Chartered Professional Accountant in Canada and Certified Professional Accountant in the U.S.

Adrian Blanco S. is the company’s Director of Operations for America and Mexico. He has extensive international experience in several industrial sectors and has held executive positions in Mexico, the United States, Peru and Argentina. He joined the McEwen Mining team in 2015 and has led a successful business transformation toward operational discipline, best business practices and financial profitability at subsidiaries Compañia Minera Pangea and McEwen Mining Nevada. He graduated from an Executive Management Program at IPADE and Harvard Business School.

Michael Meding is Vice President and General Manager of McEwen Copper. He has over 20 years of international experience, primarily with major mining companies such as Barrick Gold and Trafigura, including extensive experience with project development and operations in Argentina. While at Barrick Gold’s Veladero mine in Argentina, Mr. Meding played a key role in the turnaround, extension of the mine life and subsequent strategic partnering with Shandong Gold. He holds an MBA from Indiana University in Pennsylvania and an MBA from the Leipzig Graduate School of Management in Germany.

McEwen Mining Inc. (NYSE: MUX), closed Monday's trading session at $8, off by 4.4205%, on 75 volume. The average volume for the last 3 months is 447,205 and the stock's 52-week low/high is $5.92/$12.50.

Recent News

Software Effective Solutions Corp. (OTC: SFWJ)

The QualityStocks Daily Newsletter would like to spotlight Software Effective Solutions Corp. (OTC: SFWJ).

Prior to the passage of the 2018 Farm Bill, it was illegal to cultivate industrial hemp in the United States. Now Lincoln University is heading a project funded by the federal department of agriculture studying the crop. The project received $5 million through the Partnerships for Climate-Smart Commodities program, which is focused on supporting farmers who cultivate products with climate benefits. The program is part of the federal agriculture department's broader objective of mitigating climate change through agricultural market-driven solutions. Currently, over 100 projects are being funded by the federal department of agriculture, focusing on crops like rice, soybeans, and cotton. At the moment, the researchers are cultivating 3 hemp types; hemp for grain, hemp for fiber, and for both. In addition, they plan to convert hemp oil into a biofuel that can be used for transportation and heating. The researchers theorize that these end products will be more renewable as well as sustainable. Cody Bagnall, a research scientist partnering on Lincoln's project, adds that hemp has the potential to replace synthetic products with natural ones, which is good for the climate. Hopefully, such studies uncover new uses of hemp that industry players like Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) can leverage to add to their extensive list of hemp-based products.

Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) is a global infrastructure and holding company in the cannabis industry. MedCana currently has five companies focused on pharmaceutical cannabis production, as well a software company focused on managing processes for plant-to-patient operations. The recent acquisition of an irrigation and greenhouse technology company has rounded out MedCana’s portfolio of holdings.

MedCana’s focus is on developing clients and companies in Latin America, initially in Colombia, and partnerships with laboratories, research facilities and hospitals throughout the world. MedCana is building the technology, laboratories, growing facilities and scientific teams to provide premium pharmaceutical-grade cannabis extracts to the world.

MedCana’s goal is to be the world’s premier resource for pharmaceutical cannabis products. The company believes its advantage is its global view and reach. From initial cultivation to final product, MedCana aims to help partners produce pharmaceutical CBD and other extracts that will have no equal.

The company’s mission is to utilize its technology to partner with and develop companies that provide premium pharmaceutical-grade cannabis extracts with absolute integrity, sustainability and social responsibility. MedCana’s team of pharmaceutical scientists includes some of the most respected chemists in the world. They aim to ensure that the company’s customers and partners create premium cannabis extracts that meet the growing worldwide demand. MedCana’s software is designed to ensure traceability and quality from seed to finished product.

MedCana is headquartered in Austin, Texas, with offices in Colombia.

Production

MedCana announced in May 2023 the beginning of full-scale production of non-THC cannabis for export to Europe in response to high demand in that market. This expansion comes after the successful completion of full crop cycle testing and infrastructure development at production sites in Columbia.

The recent acquisition of the assets of Tokan Corp., a software company focused on creating an enterprise resource planning (ERP) platform for the cannabis industry, and Eko2O S.A.S., a greenhouse and irrigation engineering company, has positioned MedCana for explosive growth in the region.

As a MedCana subsidiary, Eko2O SA will increase the company’s revenue potential in Central and South America. The subsidiary specializes in the construction and distribution of greenhouses and sophisticated irrigation platforms. A positive outlook has resulted from the company’s expansion as it investigates new opportunities for greenhouse and irrigation system installations in Panama and Uruguay. These opportunities are expected to accelerate Eko2O’s development and strengthen its position as a top supplier of innovative agricultural solutions in cannabis and other sectors that are quickly moving to high technology agricultural production.

In addition, MedCana has started talks with the government in Argentina about possible incentives for beginning operations in that country as part of its ongoing worldwide development strategy. Support from the Argentinean government and the start of new operations there would greatly increase MedCana’s market share in Latin America and solidify the company’s position as the market leader in the cannabis industry.

Market Opportunity

According to a report by Grand View Research, a San Francisco-based market research and consulting company, the global cannabis extract market was valued at $3.5 billion in 2022 and is expected to expand at a CAGR of 20% from 2023 to 2030 to be worth more than $15 billion.

Growing demand for cannabis extracts, including oils and tinctures, and the increased legalization of marijuana for the treatment of different chronic ailments like arthritis, Alzheimer’s, anxiety and cancer are driving the expansion of the industry. The marijuana derivative industry is flourishing due to a greater understanding of its various medical benefits.

Management Team

Jose Gabriel Diaz is CEO of MedCana. He has successfully built, grown and sold multiple telecom companies. He was senior vice president of sales at IP Communications, a national high-speed data provider. He also founded Reallinx, a national data carrier later sold to GTT Communications. Additionally, he is currently president of the A.E.M. Business and Entrepreneurship Association in Austin, Texas.

Claudio Jiménez Cartagena, QF, Ph.D. is Chief Scientific Officer at MedCana. He joined MedCana after working with Sosteli Pharma as Technical Director and serving as a director consultant for the Corporation for Agricultural Industrial Development at the University of Antioquia in Colombia. Before that, he worked as the scientific director at the Institute of Food Science & Technology. He holds a bachelor’s degree in pharmaceutical chemistry, a master’s degree in basic biomedical sciences and a doctoral degree in Environmental Engineering from the University of Antioquia.

Julián Alberto Londoño Londoño, Ph.D., is Senior Vice President of Operations at MedCana. He previously served as general manager for the Corporation for Agricultural Industrial Development, and as Chief Scientific Officer at Sosteli Pharma in the Resource Management Department. He has developed multiple U.S. patents, and recently served as senior advisor to the Secretariat of Agriculture Development for the Government of Antioquia. He holds a doctorate in Chemical Sciences from the University of Antioquia.

Software Effective Solutions Corp. (OTC: SFWJ), closed Monday's trading session at $0.013, off by 7.1429%, on 9,991 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0071/$0.09.

Recent News

Life Electric Vehicles Holdings Inc. (OTC: LFEV)

The QualityStocks Daily Newsletter would like to spotlightFathom Life Electric Vehicles Holdings Inc. (OTC: LFEV) .

Life Electric Vehicles Holdings Inc. (OTC: LFEV) (d/b/a Life EV Group), along with its subsidiaries, is a developer, manufacturer and distributor in the light electric vehicle industry. The company’s business model focuses on the launch, acquisition and consolidation of multiple brands of e-bikes, e-trikes, e-scooters and light EVs with the aim of positioning itself as an industry leader for the American micro-mobility market.

The light electric vehicle industry, mainly e-bikes, is fast becoming a leading form of EV sales in the U.S. and Europe. In addition to offering ready-to-ride electric vehicles, Life EV Group intends to distribute individual components, including motors, batteries, chargers, controllers and EV parts, to third party manufacturers in both the U.S. and worldwide.

The company’s first acquisition was completed in 2023 with a 40% equity stake in LEV Manufacturing Inc., a related company and American manufacturer of e-bikes. LEV Manufacturing’s assembly utilizes free-trade zone processes with a U.S. Certificate of Origin, eliminating middle layer costs and resulting in cost-effective production and lower MSRPs.

LEV Manufacturing recently completed the acquisition of Serial 1 Cycle Company LLC. Serial 1 is an e-bike maker founded by U.S. motorcycle manufacturer Harley-Davidson in 2018 and spun off as an independent brand in 2020. The acquisition positions Serial 1 for even greater success and long-term growth.

Life EV Group is headquartered in Deerfield Beach, Florida.

Market Opportunity

An analysis from Mordor Intelligence, a market research and advisory firm, estimates the e-bike market to be worth $34.98 billion in 2024 and projects it will expand to reach a value of $51.78 billion by 2029, representing a CAGR of 8.16% during the forecast period.

Mordor attributes forecast market growth primarily to the increasing adoption of electric bikes as a mode of daily transportation around the world. The market is seeing an upsurge in unit sales based on their attractive consumer characteristics, including health benefits, affordability and convenience.

The North American electric bike market is growing as the preference for low-speed two- and three-wheelers has increased in recent years. Various bike-sharing operators are including electric bikes in their fleets, which is expected to support the sales growth of these bikes in the near future.

Management Team

Robert Provost is the CEO of Life EV Group. He was Founder and CEO of Prodeco Technologies, a maker of e-bikes and e-bike parts and accessories. He also serves as President and CEO of LEV Manufacturing Inc. He is Chairman of the board for Serial 1 Cycle Company.

Daniel Del Aguila is COO at Life EV Group. He co-founded Prodeco Technologies and serves as COO of LEV Manufacturing Inc.

Ivan Drusc is CFO at Life EV Group. He is a seasoned accounting and finance professional with a proven track record in industries from insurance to IT and property management. He has served as a key player in businesses ranging in size from startups to publicly traded global companies. He has experience in cost reduction, risk mitigation, IT and ERP systems, outsourcing and restructuring. He is a graduate of the University of Akron with a bachelor’s degree in accounting.

Life Electric Vehicles Holdings Inc. (OTC: LFEV), closed Monday's trading session at $2.13, up 119.5876%, on 312,301 volume. The average volume for the last 3 months is 4,648,693 and the stock's 52-week low/high is $0.851/$4.00.

Recent News

Mullen Automotive Inc. (NASDAQ: MULN)

The QualityStocks Daily Newsletter would like to spotlight Mullen Automotive Inc. (MULN).

Mullen Automotive Inc. (NASDAQ: MULN) is a Southern California-based automotive company that owns and partners with several synergistic businesses working toward the unified goal of creating clean and scalable energy solutions. Mullen has evolved over the past decade in sync with consumers and technology trends. Today, the company is working diligently to provide exciting EV options built entirely in the United States and made to fit perfectly into the American consumer’s life. Mullen strives to make EVs more accessible than ever by building an end-to-end ecosystem that takes care of all aspects of EV ownership.

Commencement of Trading on Nasdaq

On November 5, 2021, Mullen announced its commencement of trading on the Nasdaq Capital Market.

“Today is a monumental day for Mullen Automotive. I am especially proud of our team, investors and all who have believed in Mullen and taken us to this point as a publicly traded company on the Nasdaq Capital Market,” David Michery, CEO and Chairman of Mullen Automotive, stated in the news release. “Trading on Nasdaq now opens us up to new investors, both institutional and retail shareholders, and broadens our awareness and company profile, while increasing awareness of Mullen and our technology platform and opening new opportunities in EV and beyond. The road ahead has never been brighter for Mullen, and I am proud to lead us into the future.”

The milestone came in the wake of the company’s stock-for-stock merger with Net Element Inc.

The Mullen FIVE

The Mullen FIVE EV Crossover, debuting at the Los Angeles International Auto Show (LAIAS) on November 17, 2021, embodies Mullen’s Southern California roots with an inspired design focused on two complementary Golden State themes – California landscape and California urban.

The FIVE is built on an EV Crossover skateboard platform that offers multiple powertrain configurations and trim levels in a svelte design that is Strikingly Different™ and exciting to experience in person.

Prior to the start of LAIAS, the Mullen FIVE was selected as a finalist by the LA Auto Show for Top EV SUV in the ZEVA “People’s Choice” Awards.

LAIAS provides Mullen an opportunity to display multiple variants of the FIVE model while also showcasing its powertrain, battery and charging technology. The company intends to bring the FIVE to market in 2024, and reservations are currently open here.

Mullen’s development portfolio also includes EV Fleet Vans, which it intends to bring to market in Q2 2022, and the pure electric, high performance Mullen DragonFLY.

Expansion of Manufacturing Capacity

On November 2, 2021, Mullen announced plans to expand its facility in Robinsonville, Mississippi.

Mullen’s Advanced Manufacturing and Engineering Facility (AMEC) currently occupies 124,000 square feet of manufacturing space. The total available land on the property is over 100 acres, and Mullen is moving ahead with plans to build out another 1.2 million square feet of manufacturing space to support class 1 and class 2 EV cargo vans and the Mullen FIVE EV Crossover.

On the expanded site, Mullen plans to build a body shop, a fully automated paint shop and a general assembly shop.

EV Market Outlook

The global EV market was reported to consist of 3,269,671 units in 2019, a figure that is expected to grow at a CAGR of 21.1% through 2030 to a total of 26,951,318 units worldwide. This market’s monetary value was estimated at $162.34 billion in 2019 and is expected to grow at a CAGR of 22.6%, resulting in an approximate value of $802.81 billion by 2027. The primary driver for this exponential growth is a worldwide increase in vehicle emissions regulations.

Management Team

David Michery is the CEO and Founder of Mullen and has been leading the company and its divisions since inception in 2014. With over 25 years of executive management, marketing, distressed assets, and business restructuring experience, Mr. Michery brings a wealth of relevant knowledge and expertise to the Mullen brand. He has notably created 12 trademarks so far to develop the company brand and vision.

Mr. Michery is working toward a sustainable future accessible to all by creating a suite of clean-energy electric vehicles at varied price points. With entirely U.S.-based manufacturing and operations, he is also determined to have Mullen Technologies play a role in shaping a self-sustaining local economy by creating more jobs in America.

Mr. Michery manages risks and company expectations as a pathway to success and has personally overseen several businesses that totaled over $1 billion in transactions. His key strength is the ability to be fiscally responsible and lead teams to complete projects on time and within budget. As a seasoned professional in this space, Mr. Michery has demonstrated skill in building businesses from the ground up and into successful entities that subsequently sold for hundreds of millions of dollars.

Mullen Automotive Inc. (MULN), closed Monday's trading session at $0.5053, up 13.5761%, on 498,171 volume. The average volume for the last 3 months is 8,085,568 and the stock's 52-week low/high is $0.3605/$1204.99.

Recent News

HealthLynked Corp. (OTCQB: HLYK)

The QualityStocks Daily Newsletter would like to spotlightFathom HealthLynked Corp. (OTCQB: HLYK) .

HealthLynked Corp. (OTCQB: HLYK) is at the forefront of a transformative movement in healthcare, utilizing its extensive collection of health data to improve care for all. With a commitment to leveraging its advanced technology platforms, HealthLynked employs a sophisticated, cloud-based network that serves as a comprehensive repository for personal health data. This system not only simplifies the management and archiving of medical records but also enables the application of AI to deliver personalized healthcare insights. Through deep analysis of this data, HealthLynked’s AI capabilities help identify the root causes of diseases, tailor healthcare solutions to individual needs, and accelerate medical discoveries.

HealthLynked Corp. App

In addition to these capabilities, HealthLynked provides a user-friendly platform for booking healthcare appointments, similar to how OpenTable operates for restaurant reservations. This feature allows patients to conveniently book appointments with healthcare providers across the country, including options for telemedicine consultations, enhancing accessibility and efficiency in healthcare service delivery.

Strategically headquartered in Naples, Florida, HealthLynked operates through three primary divisions: Health Services, Digital Healthcare, and Medical Distribution. Each division supports the company’s mission to revolutionize patient care and health management. Positioned as a potential leader in healthcare AI, HealthLynked is dedicated to shaping the future of the industry over the next 20 years, driving significant advancements in healthcare accessibility and effectiveness through innovation and technology.

HealthLynked Corp. Reach

Strategic Initiatives and Operational Highlights

The company’s commitment to enhancing global health is evident in its dual goals: transforming healthcare through advanced technology and creating a patient-centric network that accelerates medical discoveries and the development of disease cures.

HealthLynked’s intellectual property portfolio is robust and strategically developed to enhance healthcare delivery and management. In March 2023, HealthLynked was granted a patent for a groundbreaking healthcare-specific wireless access point, known as the “Patient Access Hub.” This technology significantly improves the efficiency of healthcare practices by enabling real-time monitoring of patient flow within facilities. It intelligently determines patients waiting in exam rooms and calculates wait times, alongside other critical practice metrics. This system not only enhances patient experience by reducing unnecessary wait times but also optimizes resource allocation within healthcare settings.

Additionally, in October 2023, HealthLynked filed a patent application for its advanced AI program, ARI (Augmented Real-time Interface). ARI acts as a virtual doctor for patients, capable of performing medical intake, booking appointments, and providing personalized medical recommendations based on a patient’s medical history. By integrating these tasks, ARI streamlines the healthcare process, reducing the administrative burden on healthcare providers and ensuring that patients receive timely and tailored healthcare advice. This AI-driven interface enhances the accessibility and personalization of healthcare, embodying HealthLynked’s commitment to leveraging technology for better health outcomes. The company recently launched HealthLynked 3.2.0, an advanced version of its application, incorporating telemedicine, AI-driven personal healthcare guidance, and remote patient monitoring – setting a new standard in healthcare technology.

Market Position and Future Outlook

According to Facts and Figures Research, a research and consulting firm, the global market for patient-centric healthcare applications is projected to reach $41.6 billion by 2030, growing at a CAGR of 18.77% from 2022. HealthLynked’s offerings align perfectly with this expansive market opportunity, especially with increasing demands for digital health solutions and data management in healthcare.

HealthLynked’s strategic direction, spearheaded by its seasoned management team, is designed to leverage these market dynamics, enhancing patient engagement and healthcare efficiency on a global scale.

Management Team

Michael T. Dent, M.D., Founder, CEO, and Chairman, brings extensive experience from his foundational role at NeoGenomics and leadership in various healthcare and technology sector companies.

David Rosal, CFO, with previous senior roles at Teradata and McDonald’s Corporation, brings a wealth of expertise in financial and business integration strategies essential for growth and operational efficiency.

Chris Hall, CTO, with a strong background in global technology development from his time at Siemens and several patents to his name, is instrumental in driving the innovation and technological advancement at HealthLynked.

Bill Crupi, Operations Manager, has a proven track record in streamlining operations and enhancing productivity across multiple sectors within the healthcare industry. His expertise is crucial in maintaining the operational excellence that HealthLynked is known for.

Michael Paisan, Director of Investor Relations, leverages his extensive experience in finance and communications to enhance HealthLynked’s relationships with investors and stakeholders, ensuring transparent and effective communication of the company’s value and growth strategy.

Gagan Babber, Manager of Software Development, oversees the HealthLynked development teams based in the U.S. and India. With a robust background in engineering and software development, he plays a critical role in guiding the technological direction of HealthLynked’s products. His expertise in developing scalable, innovative software solutions is essential for driving the company’s technical initiatives forward and ensuring that HealthLynked stays at the forefront of digital healthcare technology.

HealthLynked Corp. (OTCQB: HLYK), closed Monday's trading session at $0.0185, up 19.3548%, on 78,666 volume. The average volume for the last 3 months is 538,410 and the stock's 52-week low/high is $0.0031/$0.0981.

Recent News

Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF)

The QualityStocks Daily Newsletter would like to spotlight Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF).

Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) is a strategic minerals company focused on locating and developing economic properties in the strategic metals and advanced materials space. The company aims to improve domestic specialty mineral infrastructure efficiencies to meet surging national demand from North American manufacturers, effectively positioning itself as one of the only North American suppliers of high purity natural graphite for hi-tech applications.

Reflex Advanced Materials is based in Vancouver, British Columbia. Its project portfolio includes the Ruby Graphite Deposit in Montana and the ZigZag Lithium Property in Ontario.

Projects

Ruby Graphite Project

Located in a mining-friendly jurisdiction in southwest Montana, the Ruby Graphite Deposit is a low cost, rapid re-entry opportunity that produced roughly 2,400 tons of graphite from 1902 to 1948. Reflex Advanced Materials holds mining rights for 755 hectares at the Ruby Graphite Project, with 96 federal lode mining claims. Recent samples assay at 95.8% to 98.4% total carbon.

The site is notable as the only combined U.S. graphite flake and vein graphite source. Vein graphite is ideal for energy storage applications, because it requires fewer steps to achieve purity than synthetic alternatives and is therefore far less environmentally damaging. This is expected to play a key role in the project’s development as demand for electric vehicles continues to surge.

In March 2023, the company announced its submittal of permit applications to the Bureau of Land Management in respect of its exploration of the Ruby Graphite Project. Its initial drill program, expected to take place in the summer of 2023, includes plans for 3,500 total meters of drilling, cored to an average depth of 130 meters. The targets for this drill program have been identified using historical data from original mine operations and data gathered for the initial 43-101 technical report on the project, dated January 31, 2023.

ZigZag Lithium Property

Located in the Thunder Bay Mining Division of Ontario, the ZigZag Lithium Property consists of eight mining claims spanning roughly 2,710 hectares. Mineralization at the property, most notably lithium, is based in pegmatite dikes and concentrated in spodumene crystals, which are consistent throughout the entire unit.

Spodumene is readily observable in outcrops and in drill cores, with crystal sizes ranging from 3-15cm, on average.

Reflex Advanced Materials and American Energy Technologies Company Metallurgical Partnership

Reflex Advanced Materials has entered into a material processing agreement with American Energy Technologies Co., which is based in Arlington Heights, Illinois, to conduct metallurgical testwork with the goal of creating a technical support data package for Reflex’s target customer base, U.S. Federal agencies and qualification programs with hi-tech customers in the battery and battery storage business.

The resulting coated, spherionized, purified graphite (CSPG) material that is expected to be created from the aforementioned tests will be used to provide potential customers of CSPG with samples so that they can begin the material qualification process.

Market Opportunity

Graphite is an ideal battery anode and has dominated the market since the proliferation of lithium-ion batteries. Despite this demand, there is currently no significant production of lithium-ion battery anode material in North America.

Instead, most graphite sold in North America today is sourced from Chinese producers. U.S. President Joe Biden highlighted this sourcing disparity in a 2022 address:

“The United Stated depends on unreliable foreign sources for many of the strategic and critical materials necessary for the clean energy transition – such as lithium, nickel, cobalt, graphite and manganese for large-capacity batteries,” he said. “Demand for such materials is projected to increase exponentially as the world transitions to a clean energy economy.”

The U.S. Department of Energy is in the process of awarding $2.8 billion to expand domestic manufacturing of batteries for electric vehicles and combat this foreign dependency. Reflex Advanced Materials has identified its Ruby Graphite Project as a prime candidate for U.S.-sponsored initiatives due to the rarity and scarcity of natural graphite deposits in the country.

Processing graphite domestically in the U.S. is expected to provide Reflex Advanced Materials a competitive advantage as manufacturers begin to seek out American supply in the face of increased diplomatic tension. This is critical, as a rise in anode demand is expected to fuel a shortage of 8 million tonnes of graphite by 2040. World Bank Group projects 494% growth in total graphite demand by 2050.

Leadership Team

Paul Gorman is the CEO and a Director of Reflex Advanced Materials. He brings to the company over 25 years of experience in junior mining finance, public listings, viability assessment and operational rationalization. For 18 years, Mr. Gorman served as president and managing partner of Riverbank Capital, where he played an instrumental role in raising more than $85 million for small-cap companies. In 2008, he funded Industrial Minerals Inc. (later Northern Graphite) and served in an advisory role for four other graphite companies, contributing significantly to the revitalization of the junior graphite space in North America. Mr. Gorman founded Mega Graphite Inc. in 2009 and has served as chief executive for three other companies.

Tasheel Jeerh, CPA, is the company’s CFO. He is a finance and accounting professional with over a decade of experience spanning both public and private sectors. Prior to joining Reflex Advanced Materials, Mr. Jeerh played a pivotal role in the growth of a private upstream oil and gas firm, dealing with over $2 billion in M&A activity and $1 billion in financing activities. He gained his designation at PricewaterhouseCoopers, where he worked as a manager in the assurance practice.

Greg Bell is Project Manager for Reflex Advanced Materials. He is a multi-disciplined engineering management professional with more than 40 years of experience in the natural resources sector. Mr. Bell has successfully built and managed several start-up operations in various capacities. He has been active in graphite and lithium exploration for the past seven years.

Christopher W. Hill leads the company’s Corporate Development initiatives. He is an investor and entrepreneur with over a decade of experience in the capital markets. Mr. Hill began his career as an investment advisor and then began to consult and advise private companies on their paths to becoming publicly traded. He specializes in corporate development and strategic financing utilizing his large network in the capital markets.

Reflex Advanced Materials Corp. (RFLXF), closed Monday's trading session at $0.031, up 24.7485%, on 43,676 volume. The average volume for the last 3 months is 5,260 and the stock's 52-week low/high is $0.0077/$0.2269.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.